<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76555</article-id><article-id pub-id-type="doi">10.7554/eLife.76555</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Metabolic basis for the evolution of a common pathogenic <italic>Pseudomonas aeruginosa</italic> variant</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-266487"><name><surname>Mould</surname><given-names>Dallas L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6939-1351</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266488"><name><surname>Stevanovic</surname><given-names>Mirjana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-266489"><name><surname>Ashare</surname><given-names>Alix</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-250862"><name><surname>Schultz</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-264863"><name><surname>Hogan</surname><given-names>Deborah A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6366-2971</contrib-id><email>dhogan@dartmouth.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/049s0rh22</institution-id><institution>Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth</institution></institution-wrap><addr-line><named-content content-type="city">Hanover</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00d1dhh09</institution-id><institution>Department of Medicine, Dartmouth-Hitchock Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Lebanon</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cooper</surname><given-names>Vaughn S</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Storz</surname><given-names>Gisela</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04byxyr05</institution-id><institution>National Institute of Child Health and Human Development</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>03</day><month>05</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e76555</elocation-id><history><date date-type="received" iso-8601-date="2021-12-21"><day>21</day><month>12</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-04-24"><day>24</day><month>04</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-01-14"><day>14</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.01.14.476307"/></event></pub-history><permissions><copyright-statement>© 2022, Mould et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Mould et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76555-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-76555-figures-v2.pdf"/><abstract><p>Microbes frequently evolve in reproducible ways. Here, we show that differences in specific metabolic regulation rather than inter-strain interactions explain the frequent presence of <italic>lasR</italic> loss-of-function (LOF) mutations in the bacterial pathogen <italic>Pseudomonas aeruginosa</italic>. While LasR contributes to virulence through its role in quorum sensing, <italic>lasR</italic> mutants have been associated with more severe disease. A model based on the intrinsic growth kinetics for a wild type strain and its LasR<sup>–</sup> derivative, in combination with an experimental evolution based genetic screen and further genetics analyses, indicated that differences in metabolism were sufficient to explain the rise of these common mutant types. The evolution of LasR<sup>–</sup> lineages in laboratory and clinical isolates depended on activity of the two-component system CbrAB, which modulates substrate prioritization through the catabolite repression control pathway. LasR<sup>–</sup> lineages frequently arise in cystic fibrosis lung infections and their detection correlates with disease severity. Our analysis of bronchoalveolar lavage fluid metabolomes identified compounds that negatively correlate with lung function, and we show that these compounds support enhanced growth of LasR<sup>–</sup> cells in a CbrB-controlled manner. We propose that in vivo metabolomes contribute to pathogen evolution, which may influence the progression of disease and its treatment.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Bacteria can evolve quickly, a skill that proves useful in ever-changing environments. For example, individuals in many bacterial species can start to work together under certain circumstances; this ability is underpinned by a system called quorum sensing, which allows cells to detect nearby conspecifics. However, species of harmful bacteria often lose their quorum sensing abilities when they infect humans. This is the case for <italic>Pseudomonas aeruginosa,</italic> which normally lives in the soil but can also cause deadly conditions, especially in hospital settings.</p><p>Patients often carry <italic>P. aeruginosa</italic> with mutations that disable the quorum-sensing signal receptor LasR, a molecular actor that can switch on many other genes in a cell. People who are infected with <italic>P. aeruginosa</italic> strains carrying a damaged version of the <italic>lasR</italic> gene are typically more ill and less likely to recover. Why this is the case – and in fact, why genes associated with quorum sensing often lose function during infection – is still unclear.</p><p>To investigate this question, Mould et al. used laboratory evolution experiments and computer models of <italic>P. aeruginosa</italic> growth to understand how <italic>lasR</italic> mutant cells evolve. Differences in growth rates and ways to use resources (rather than changes in cell-to-cell interactions) best explained why <italic>lasR</italic> mutants become more successful. Further experiments narrowed down the molecular cascade required for the rise of <italic>lasR</italic> mutants, identifying a pathway that regulates how <italic>P. aeruginosa</italic> switches between different nutrient sources.</p><p>This work reveals a new connection between quorum sensing genes and nutrient regulation in bacterial cells. Loss of functional LasR changes the way that cells use nutrients, and thus will reshape how they interact with host cells and other bacteria. This insight could lead to better ways to predict the outcomes of bacterial infections and how to best treat them.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>Pseudomonas aeruginosa</italic></kwd><kwd>quorum sensing</kwd><kwd>LasR</kwd><kwd>evolution</kwd><kwd>carbon catabolite repression</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>HOGAN19G0</award-id><principal-award-recipient><name><surname>Mould</surname><given-names>Dallas L</given-names></name><name><surname>Hogan</surname><given-names>Deborah A</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>ASHARE20P0</award-id><principal-award-recipient><name><surname>Ashare</surname><given-names>Alix</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>STANTO19R0</award-id><principal-award-recipient><name><surname>Schultz</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000897</institution-id><institution>Cystic Fibrosis Foundation</institution></institution-wrap></funding-source><award-id>T32AI007519</award-id><principal-award-recipient><name><surname>Mould</surname><given-names>Dallas L</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01HL122372</award-id><principal-award-recipient><name><surname>Ashare</surname><given-names>Alix</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM130454</award-id><principal-award-recipient><name><surname>Stevanovic</surname><given-names>Mirjana</given-names></name><name><surname>Schultz</surname><given-names>Daniel</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P20GM113132</award-id><principal-award-recipient><name><surname>Mould</surname><given-names>Dallas L</given-names></name><name><surname>Hogan</surname><given-names>Deborah A</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK117469</award-id><principal-award-recipient><name><surname>Mould</surname><given-names>Dallas L</given-names></name><name><surname>Ashare</surname><given-names>Alix</given-names></name><name><surname>Schultz</surname><given-names>Daniel</given-names></name><name><surname>Hogan</surname><given-names>Deborah A</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>P30CA023108</award-id><principal-award-recipient><name><surname>Mould</surname><given-names>Dallas L</given-names></name><name><surname>Ashare</surname><given-names>Alix</given-names></name><name><surname>Schultz</surname><given-names>Daniel</given-names></name><name><surname>Hogan</surname><given-names>Deborah A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Microbial variants that arise during chronic lung infections have an increased ability to use nutrients that are abundant in lung infections.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Quorum sensing (QS) is a mechanism of microbial communication that regulates the expression of a suite of genes in response to diffusible autoinducers in a population (<xref ref-type="bibr" rid="bib54">Schuster and Greenberg, 2007</xref>; <xref ref-type="bibr" rid="bib53">Schuster et al., 2003</xref>). Despite the importance of cell-cell communication for virulence (<xref ref-type="bibr" rid="bib51">Rumbaugh et al., 2009</xref>) and high conservation across divergent phylogenies, key QS regulators in diverse species, such as <italic>Pseudomonas aeruginosa</italic>, <italic>Vibrio cholerae</italic>, and <italic>Staphylococcus aureus</italic>, frequently lose function (<xref ref-type="bibr" rid="bib40">Mould and Hogan, 2021</xref>), due to recent missense and nonsense mutations, indels, or genome rearrangements. These paradoxical findings suggest that there may be connections between QS and other key physiological pathways that have yet to be revealed.</p><p>In <italic>P. aeruginosa,</italic> many isolates from humans, plants, and water sources have loss-of-function mutations in the gene encoding the transcription factor LasR (<xref ref-type="bibr" rid="bib24">Groleau et al., 2022</xref>; <xref ref-type="bibr" rid="bib44">O’Connor et al., 2021</xref>), which is central to an interconnected QS network (<xref ref-type="bibr" rid="bib53">Schuster et al., 2003</xref>). LasR<sup>–</sup> isolates have been repeatedly observed in <italic>P. aeruginosa</italic> lung infections in people with cystic fibrosis (pwCF) (<xref ref-type="bibr" rid="bib57">Smith et al., 2006</xref>), and LasR<sup>–</sup> isolate detection is associated with more rapid lung function decline and more inflammation than in comparator populations (<xref ref-type="bibr" rid="bib29">Hoffman et al., 2009</xref>; <xref ref-type="bibr" rid="bib33">LaFayette et al., 2015</xref>). In a clinical study of acute corneal infections (<xref ref-type="bibr" rid="bib25">Hammond et al., 2016</xref>), LasR<sup>–</sup> strains also correlated with more damage and worse outcomes.</p><p>Multiple studies contribute to our understanding of the physiologies and social interactions that impact LasR LOF mutant fitness. Several studies provide evidence in support of the model that LasR<sup>–</sup> strains are ‘social cheaters’ that reap the benefits of shared goods secreted by neighboring wild-type cells without incurring the metabolic costs (<xref ref-type="bibr" rid="bib52">Sandoz et al., 2007</xref>). In this case, LasR<sup>–</sup> strains grow better when the wild type is in the majority, and crash when a critical threshold of LasR<sup>–</sup> cells is surpassed due to insufficient wild-type support (<xref ref-type="bibr" rid="bib66">West et al., 2006</xref>). The extent of <italic>lasR</italic> mutant ‘cheating’ depends on the cost-benefit difference, and multiple shared goods, including siderophores, must be considered (<xref ref-type="bibr" rid="bib43">Ozkaya et al., 2018</xref>). To combat the rise of cheaters, <italic>P. aeruginosa</italic> produces products such as hydrogen cyanide, rhamnolipids, or pyocyanin that inhibit the growth of quorum sensing mutants through a process known as ‘policing’ (<xref ref-type="bibr" rid="bib6">Castañeda-Tamez et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">García-Contreras et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Wang et al., 2015</xref>). There is evidence that the presence of LasR<sup>–</sup> subpopulations may be beneficial (<xref ref-type="bibr" rid="bib22">García-Contreras and Loarca, 2020</xref>) and lead to emergent properties including metabolite-driven interactions between wild type and <italic>lasR</italic> mutants that provoke the production of QS-controlled factors by the <italic>lasR</italic> mutant to levels greater than in wild-type monocultures (<xref ref-type="bibr" rid="bib39">Mould et al., 2020</xref>). In addition to the interactions between LasR<sup>+</sup> and LasR<sup>–</sup> cells that influence the fitness and behavior of LasR<sup>–</sup> strains described above, there are important intrinsic characteristics of LasR<sup>–</sup> strains including increased Anr-regulated microoxic fitness (<xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>), resistance to alkaline pH in aerobic conditions (<xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>), and altered metabolism (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>). The metabolic advantages associated with LasR<sup>–</sup> strains include growth on individual amino acids (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>). The numerous differences described between LasR<sup>+</sup> and LasR<sup>–</sup> strains indicate that an understanding of the factors that drive the rise and persistence of <italic>lasR</italic> mutants may be complex and are not yet well understood. While it is clear that there are many ways in which <italic>lasR</italic> LOF mutants differ from their LasR +progenitors, a common trait that promotes the rise of LasR<sup>–</sup> strains in diverse environments, even in rich and minimal laboratory media (<xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>; <xref ref-type="bibr" rid="bib55">Scribner et al., 2022</xref>; <xref ref-type="bibr" rid="bib42">O Brien et al., 2017</xref>; <xref ref-type="bibr" rid="bib36">Luján et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Qi et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">Robitaille et al., 2020</xref>; <xref ref-type="bibr" rid="bib52">Sandoz et al., 2007</xref>; <xref ref-type="bibr" rid="bib71">Wong et al., 2012</xref>; <xref ref-type="bibr" rid="bib73">Yan et al., 2018</xref>), has not been established.</p><p>Here, we use mathematical modeling, experimental evolution-based genetic screens, phenotype profiling, and whole-genome sequencing of evolved communities in different backgrounds to understand the rise of LasR<sup>–</sup> strains over only a few serial passages. We identified the CbrAB pathway as the strongest contributor to the rise of <italic>lasR </italic>LOF mutants, and our findings were not specific to strain background or medium. LasR<sup>–</sup> strains are more commonly detected in samples from individuals with more severe CF lung disease (<xref ref-type="bibr" rid="bib57">Smith et al., 2006</xref>). Analysis of bronchoalveolar lavage samples from pwCF and non-CF comparators identified several compounds that were higher in pwCF and that inversely correlated with lung function. LasR<sup>–</sup> strains showed improved growth on the majority of these compounds, many of which were amino acids, and epistasis analysis confirmed that the improved growth was due to altered activity of the CbrB-CrcZ-Crc pathway.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Mathematical model built from monoculture growth data predicts the observed rise of <italic>lasR</italic> loss-of-function mutants</title><p>Our previous work on microbial interactions involving LasR<sup>+</sup> and LasR<sup>–</sup> <italic>P. aeruginosa</italic> revealed subtle differences in growth kinetics (<xref ref-type="bibr" rid="bib39">Mould et al., 2020</xref>). In monoculture, <italic>P. aeruginosa</italic> strain PA14 ∆<italic>lasR</italic> had no lag phase, while the wild type had a lag phase of 1 h (<xref ref-type="fig" rid="fig1">Figure 1A</xref> for summary data and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> for growth curve). Furthermore, consistent with work by others, the ∆<italic>lasR</italic> strain had a lower growth rate (<xref ref-type="bibr" rid="bib23">García-Contreras et al., 2020</xref>) but a 1.5-fold higher yield in LB (<xref ref-type="bibr" rid="bib14">Diggle et al., 2007</xref>). We found no differences in death rate resulting from elevated culture pH (as has previously been reported in low oxygen conditions [<xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>]) or the onset of death phase relative to PA14 wild type under these conditions (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mathematical model built from monoculture growth data is sufficient to explain the rise of LasR loss-of-function strains.</title><p>(<bold>A</bold>) Predicted densities (left y-axis) of mathematical model shown for wild type (WT, dashed line) and LasR<sup>–</sup> (solid line) strains. Predicted percentages (right y-axis) of LasR<sup>–</sup> (beige fill) and LasR+ (green fill) strains over the course of evolution regime in LB with passage (P<sub>n</sub>) every 2 days. Table shows experimentally measured growth parameters used to create the model as obtained for strains PA14 WT and ∆<italic>lasR</italic> grown in 5 mL LB cultures on a roller drum. (<bold>B</bold>) Percentage of LasR<sup>–</sup> phenotypes observed in n ≥ 4 independent evolution experiments in LB. Different shapes represent independent experiments, and same shapes represent technical replicates. A representative image of the smooth LasR+ and sheen LasR<sup>–</sup> colonies from Day 6 is shown. (<bold>C</bold>) <italic>lasR</italic> alleles detected in the population at Day 4 (4 d) and Day 6 (6 d) by PoolSeq within the <italic>lasR</italic> coding sequence, which includes the autoinducer binding and DNA binding domains, for a representative experiment (diamond symbols, in B). The percentages of each allele and the sum (i.e. % total) is indicated for each replicate culture. Each color represents a different allele. (<bold>D</bold>) LasR regulates the production of its cognate autoinducer 3OC12HSL via direct transcriptional control of the gene encoding the LasI synthase. LasI-produced autoinducer activity of evolved pools from a representative experiment (diamond symbols, in B) at days 2 and 6. Activity is presented as a percentage of that produced by unevolved WT monocultures. The levels produced by the engineered ∆<italic>lasR</italic> control strain is shown for reference (dotted line). **, p = 0.0015 as determined by two-tailed, upaired t-test. (<bold>E</bold>) Comparison of predicted (dashed line) and observed (solid line) outcomes of competition assays initiated at different initial ratios for which a constitutively tagged WT (<italic>att::lacZ</italic>) was competed against ∆<italic>lasR</italic> (beige, gray line) or WT (control, green) competitors for 6 h (final) in planktonic LB cultures with 95% confidence intervals shown for best fit line (quadratic).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Experimentally determined growth parameters of PA14 wild type and ∆<italic>lasR</italic> monocultures in LB.</title><p>Density measurements of strains PA14 wild type (WT, green) and ∆<italic>lasR</italic> (beige, gray) monocultures grown in 5 mL LB on a roller drum over time. Lag, growth rate, yield, duration of death, and death rate were determined for use in the mathematical model (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Phenotype analysis of sheen LasR<sup>–</sup> candidates isolated from the evolution experiments in LB.</title><p>LasR loss-of-function (LOF) candidates picked on basis of sheen colony morphology from evolution were screened for phenotypes associated with LasR<sup>–</sup> strains including low protease activity on milk plates and low levels of acyl homoserine lactone production as measured by ∆<italic>lasI</italic>∆<italic>rhlI</italic> bioreporters responsive to LasR-regulated autoinducer 3-oxo-C12-homoserine lactone (3OC12HSL) and RhlR-regulated autoinducer N-butyryl-L-homoserine lactone (C4HSL).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig1-figsupp2-v2.tif"/></fig></fig-group><p>We built a mathematical model of strain competition exclusively from experimentally determined monoculture growth parameters to predict the relative changes in wild type and LasR<sup>–</sup> cell numbers when grown on a common pool of growth substrates in order to determine how differences in growth kinetics alone would impact the rise of LasR<sup>–</sup> lineages (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We modeled cell density (<xref ref-type="fig" rid="fig1">Figure 1A</xref> -left y-axis) and the percentage of LasR<sup>–</sup> cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref> -right y-axis) assuming a shared nutrient source and a passage every 48 hr which is a regime used previously to study the selection for LasR<sup>–</sup> cells (<xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>). Based on the mutation frequency of the <italic>P. aeruginosa</italic> strain PA14 (0.52 × 10<sup>−3</sup> per genome per generation) (<xref ref-type="bibr" rid="bib13">Dettman et al., 2016</xref>) and the size of the <italic>lasR</italic> gene (720 bp) relative to the genome (~ 6 Mbp), we approximate 50 <italic>lasR</italic> alleles with nucleotide changes would be present in a dense culture ( ~ 10<sup>8</sup> cells), a fraction of which would lead to a LasR<sup>–</sup> phenotype. With the assumption of 2 to 20 LasR<sup>–</sup> cells per inoculum (t = 0, ~ 10<sup>5</sup> cells), the model predicted that ~ 20% of the population would consist of LasR<sup>–</sup> cells by Day 4, with increased percentages of ~ 40% and ~ 80% by Days 6 and 8, respectively (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Only minor differences in percentages resulted from changes in the initial LasR<sup>–</sup> population.</p><p>We compared the model output to experimental data gathered with the same growth conditions and evolution regime. A single PA14 wild-type colony was used to inoculate a 5 mL culture of LB, which was grown to saturation and then used to inoculate three 5 mL LB cultures which were then passaged independently. Results from all three replicates from four independent experiments are shown. The percent of cells with LOF phenotypes were enumerated by plating and determining the percent of colonies with the characteristic ‘sheen’ colony morphology of LasR<sup>–</sup> cells that result from accumulation of 4-hydroxy-2-heptylquinoline (HHQ) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; <xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>). In all four independent experiments, the percentage of colonies with the LasR<sup>–</sup> phenotype rose from undetectable levels to an average of ~ 80% over the course of 8 days (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). To validate the use of colony sheen as an indicator of the LasR<sup>–</sup> genotype, we evaluated ≥ 90 isolates with the characteristic LasR<sup>–</sup> colony morphology for other phenotypes associated with LOF: low production of proteases and autoinducers (3OC12HSL and C4HSL). Most of the predicted LasR<sup>–</sup> isolates (~ 90%) had phenotypes that mirrored those of the PA14 ∆<italic>lasR</italic> strain, and not wild type (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Consistent with other studies (<xref ref-type="bibr" rid="bib19">Feltner et al., 2016</xref>), approximately 15% of the cells with other LasR<sup>–</sup> phenotypes produced high levels of C4HSL even though 3OC12HSL production was low.</p><p>The percentage of LasR<sup>–</sup> cells predicted by the model matched the frequency of <italic>lasR</italic> alleles in genome sequence data from pools of colonies obtained from Day 4 and 6 cultures of a representative experiment (diamond symbols in <xref ref-type="fig" rid="fig1">Figure 1B</xref>). Across replicates, six non-synonymous mutations were identified in <italic>lasR</italic> in the regions corresponding to the LasR autoinducer binding (∆36–38, W60R, and L130P) and DNA binding domains (E183G, A231V, and N233Y) (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), which are important for function (<xref ref-type="bibr" rid="bib19">Feltner et al., 2016</xref>). No synonymous mutations in <italic>lasR</italic> were detected. Two mutations (∆36–38 and L130P) were present in all three replicate cultures at Day 4 and thus were likely present in the initial inoculum. In replicate A, two additional mutations in <italic>lasR</italic> (E183G and A231V) were identified at Day 6; the LasR A231V substitution has been extensively characterized as a loss-of-function mutation through phenotyping and genetic complementation (<xref ref-type="bibr" rid="bib36">Luján et al., 2007</xref>; <xref ref-type="bibr" rid="bib47">Qi et al., 2016</xref>). The percentage of <italic>lasR</italic> mutants in the evolved population detected by sequencing at Day 4 (22.2 ± 6.0% s.d.) and Day 6 (48.5 ± 4.9% s.d.) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) closely resembled the percentage of LasR<sup>–</sup> strains predicted by the model (~ 20% and ~ 50%, respectively) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The increased frequency of cells with the allele encoding the L130P substitution (<xref ref-type="bibr" rid="bib37">McCready et al., 2019</xref>) between Day 4 and Day 6, with 13.1%, 24.6%, and 41.4% increases in replicate cultures, suggests strong selection for this particular variant or the presence of an additional mutation(s) in this background. In support of the significant increases in LasR<sup>–</sup> subpopulations, the evolved cultures themselves had lower levels of the LasR-regulated autoinducer 3OC12HSL; by Day 2, culture 3OC12HSL levels were ~ 30% lower than a non-evolved wild-type culture, and showed a ~ 90% reduction by Day 6 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>To further test the predictive power of our model for the rise of LasR<sup>–</sup> lineages, we initiated cultures with different ratios of a constitutively tagged wild type (<italic>att::lacZ</italic>) against untagged wild-type or ∆<italic>lasR</italic> mutant competitors. A control assay demonstrated that the ratios of tagged and untagged wild type were unchanged over the course of growth, as indicated previously under distinct conditions (<xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>; <xref ref-type="bibr" rid="bib39">Mould et al., 2020</xref>). When the ∆<italic>lasR</italic> competitor was cultured with the tagged wild type for 6 hr, the percentage of ∆<italic>lasR</italic> mutant cells in the total population increased regardless of the initial percentage of ∆<italic>lasR</italic> (1–85%) at the time of inoculation (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). The model successfully predicted that ∆<italic>lasR</italic> would outcompete the wild type over this range which is consistent with differential growth kinetics playing a major role (<xref ref-type="fig" rid="fig1">Figure 1E</xref> -dotted line). No ∆<italic>lasR</italic> advantage would be observed when it is at high initial percentages if its advantage was solely due to exploitation of common goods, as is observed when WT and ∆<italic>lasR</italic> are co-cultured on a substrate that requires WT protease production (<xref ref-type="bibr" rid="bib52">Sandoz et al., 2007</xref>). There were differences between the best fit lines for the actual and predicted data that could be due to a variety of factors including measurement error or biological interactions between WT and ∆<italic>lasR</italic> strains (e.g policing <xref ref-type="bibr" rid="bib6">Castañeda-Tamez et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Wang et al., 2015</xref>).</p></sec><sec id="s2-2"><title>Activity of CbrAB, the two-component system that regulates carbon utilization, is required for the rise of LasR<sup>–</sup> strains</title><p>To test which genes or pathways were required to promote the selection of LasR<sup>–</sup> cells, we applied reverse genetics to experimental evolution. In <italic>P. aeruginosa,</italic> the sensor kinases of two-component systems, encoded throughout the genome, respond to a variety of diverse internal and environmental cues, such as nutrient limitation or stresses, that may be relevant to differential fitness (<xref ref-type="bibr" rid="bib50">Rodrigue et al., 2000</xref>; <xref ref-type="bibr" rid="bib65">Wang et al., 2021</xref>). Using a library of 63 sensor kinase deletion mutants (<xref ref-type="bibr" rid="bib65">Wang et al., 2021</xref>), we screened each mutant for the rise of LasR<sup>–</sup> phenotypes in triplicate in a 96-well plate format (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). In the primary microtiter dish-based screen, in which the investigators were blind to mutant strain identity, five gene knock-outs (<italic>∆cbrA,</italic> ∆<italic>gacS,</italic> ∆<italic>fleS,</italic> ∆PA14_64580<italic>,</italic> and ∆PA14_10770) showed no detectable ‘sheen’ colony phenotypes characteristic of LasR<sup>–</sup> strains in any of the three replicates (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref> &amp; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). In a secondary screen of these five mutants in five mL cultures, only the ∆<italic>cbrA</italic> mutant (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) did not evolve LasR<sup>–</sup> phenotypes after serial passage; the other four mutants all had significant subpopulations with LasR<sup>–</sup> phenotypes by Day 6 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>). LasR<sup>–</sup> strains rose with a similar frequency as in the wild type progenitor when evolution experiments were initiated with strains lacking the regulator Anr, important for LasR<sup>–</sup> microoxic fitness, or the regulator RhlR, important for <italic>lasR</italic> mutant policing (<xref ref-type="bibr" rid="bib7">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>) suggesting that these regulators were not major contributors to fitness under these conditions (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Activity of the carbon catabolite repression system is required for LasR<sup>–</sup> selection in LB.</title><p>(<bold>A</bold>) The percentage of colonies with LasR<sup>–</sup> phenotypes enumerated over the course of evolution for ∆<italic>cbrA</italic> or ∆<italic>cbrB</italic> mutants (purple triangle and square, respectively) in strains PA14 or a LasR+ cystic fibrosis isolate (DH2417) relative to ‘wild-type‘ comparators. PA14 WT strain data is the same as in <xref ref-type="fig" rid="fig1">Figure 1B</xref> (n ≥ 3). Statistical significance was determined between percent LasR<sup>–</sup> phenotypes in CbrA/B + and <italic>cbrA/B</italic> mutant pools each day via Two-Way ANOVA with Dunnet’s multiple hypothesis correction. For all panels: *, p &lt; 0.05; **, p &lt; 0.005; ***, p &lt; 0.0005; ****, p &lt; 0.0001. (<bold>B</bold>) The carbon catabolite repression system promotes the preferential consumption of succinate (and other preferred substrates) through the two-component system CbrAB. CbrA activates its response regulator CbrB which directly induces expression of the small RNA <italic>crcZ. crcZ</italic> sequesters Crc thereby allowing translation of the target gene to occur. Often the target gene enables the utilization of specific (i.e. less preferred) substrates. In a catabolite repressed state, such as when succinate is present, Crc binds to target mRNA with the RNA binding protein Hfq and blocks translation. CbrB protein levels are higher in strains lacking LasR function, but the mechanism linking these pathways is uncharacterized. (<bold>C</bold>) Percent total mutant alleles in <italic>lasR</italic> (pink bar), <italic>fleR</italic> (gray bar), <italic>crc</italic> (light blue bar), and <italic>hfq</italic> (darker blue bar) in a representative experiment (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, diamond symbols) for PA14 wild type, ∆<italic>cbrA</italic>, ∆<italic>cbrB</italic> evolved populations sequenced on Day 4 (white filled symbol) and six (gray filled symbol). Representative image of the larger colony morphologies observed in the evolved pools from CbrA/B- deficient strains (∆<italic>cbrA</italic> shown) above. (<bold>D</bold>) Crc represses <italic>amiE</italic> encoding an amidase that can turnover the fluoroacetamide (FAA) protoxin to fluoroacetate (FA) mediating cell death. In the presence of succinate, cells with functional Crc survive in the presence of FAA. PA14 WT, PA14 ∆<italic>cbrA</italic>, PA14 ∆<italic>cbrB</italic>, and DH2417 WT strains were included as controls. The <italic>∆cbrA</italic> and <italic>∆cbrB</italic> parental strains used for the evolution experiments and representative colonies that emerged with a larger colony size in these backgrounds were patched (or struck out) onto succinate containing plates in the absence and presence of the FAA protoxin. (<bold>E</bold>) <italic>crcZ</italic> expression of PA14 ∆<italic>lasR</italic> in LB (white bar) and LB with 40 mM succinate (blue bar) measured by qRT-PCR and plotted relative to expression of ∆<italic>lasR</italic> in LB (n = 4). Inset shows representative image of ∆<italic>lasR, ∆lasR∆crc</italic>, and ∆<italic>lasR∆crc +crc</italic> grown on succinate containing plates in the absence and presence of FAA. (<bold>F</bold>) Percentage of colonies with LasR<sup>–</sup> phenotypes observed in evolution experiment initiated with strain PA14 WT in LB supplemented with 40 mM succinate (n = 6). P-values of 0.007 and 0.005 for comparison of ∆<italic>lasR∆cbrB</italic> (LB) and ∆<italic>lasR</italic> (LB +succinate) relative <italic>to ∆lasR</italic> grown in LB as determined by ordinary one-way ANOVA with Dunnett’s multiple comparison test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Screen reveals specific requirement of CbrA, and not other sensor kinases encoded in the PA14 genome for LasR<sup>–</sup> strain selection.</title><p>Circos plot of the PA14 genome, with the genomic location of the genes deleted to create the kinase mutant collection indicated by lines in the inner circle (and noted in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>); outer ticks indicate 4 × 10<sup>5</sup> bp genome increments. The primary screen (1°) was performed in a 96-well plate format in LB with each strain in triplicate. Deletion backgrounds that had zero, one, two, or three replicates containing LasR<sup>–</sup> phenotypes at the time of plating (i.e. when all wild-type controls had &gt;50% colonies with LasR<sup>–</sup> phenotypes) are represented as lines colored purple, blue, or gray, respectively, with decreasing line thickness. Deletion mutants that were found to have zero colonies with LasR<sup>–</sup> phenotypes (thick dark purple lines, gene names indicated) were secondarily screened in 5 mL LB evolution assays (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>); only ∆<italic>cbrA</italic> (filled in purple) was negative (-) for LasR<sup>–</sup> phenotypes in the secondary screen (2°).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>LasR<sup>–</sup> strains evolve in all tested strain backgrounds except for those deficient in <italic>cbrAB,</italic> and this is independent of cellular density, lysis, and filtrate toxicity.</title><p>(<bold>A</bold>) Kinase deletion mutant backgrounds that did not evolve LasR<sup>–</sup> phenotypes in any replicate of a 96-well evolution (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>) were secondarily screened for the appearance of LasR<sup>–</sup> colonies in 5 mL cultures. The colony phenotypes were quantified over time with percentage of LasR<sup>–</sup> phenotypes indicated (beige). (<bold>B</bold>) The percent of colonies with LasR<sup>–</sup> phenotypes observed for LB evolution experiments initiated with strains PA14 ∆<italic>rhlR</italic> or ∆<italic>anr</italic> relative to wild type. (<bold>C</bold>) Optical density for PA14 wild type (WT, green) or ∆<italic>cbrA</italic> (purple) cultures over course of evolution in LB (circles, n ≥ 9) or LB buffered to pH 7 with HEPES (circle with ‘x’, n ≥ 3). Points represent the average and error bars, standard deviation. Statistical significance between WT and ∆<italic>cbrA</italic> determined by two-way ANOVA with Šídák’s multiple comparisons test for LB and buffered LB datasets separately. For LB: Day 1, p &lt; 0.0001. For buffered LB: Day 1, p = 0.023 and Day 6, p &lt; 0.009. All other comparisons are non-significant. D. Percentage of colonies with LasR<sup>–</sup> phenotypes over the course of evolution in buffered LB for PA14 WT (circles), ∆<italic>cbrA</italic> (triangles) or <italic>cbrB</italic>::tn<italic>M</italic> (squares), or DH2417 LasR +clinical isolate (diamonds) (n ≥ 3). E. Density (i.e. total colony forming unit counts) of PA14 <italic>∆lasR</italic> after 24 hr of growth in filtrate from saturated PA14 wild type or ∆<italic>cbrB</italic> cultures. ns, not significant as determined by Student’s paired two-tailed t-test. P-value = 0.9597.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig2-figsupp2-v2.tif"/></fig></fig-group><p>CbrA, through its regulation of the response regulator CbrB, (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Sonnleitner et al., 2009</xref>), controls <italic>P. aeruginosa</italic> preferential catabolism of certain carbon sources, such as succinate, over others (e.g. amino acids) through a process referred to as catabolite repression. In support of the finding that CbrA was essential for the evolution of LasR<sup>–</sup> lineages, the ∆<italic>cbrB</italic> mutant also showed a striking and significant reduction in LasR<sup>–</sup> phenotypes over the course of 8 days (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Additionally, evolution experiments in a LasR<sup>+</sup> cystic fibrosis clinical isolate (DH2417) showed a similar rise in LasR<sup>–</sup> phenotypes over the course of evolution, which was delayed and reduced in a ∆<italic>cbrB</italic> derivative (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). CbrAB-controlled catabolite repression is regulated by Crc, in complex with the RNA-binding protein Hfq, which together repress the translation of target mRNAs involved in the transport and catabolism of less preferred substrates (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib59">Sonnleitner et al., 2017</xref>). Crc activity is down regulated by the small RNA <italic>crcZ</italic>, which sequesters Crc away from its mRNA targets. The CbrAB two-component system transcriptionally regulates levels of <italic>crcZ</italic> (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib58">Sonnleitner et al., 2009</xref>) in response to signals that have yet to be described.</p><p>Consistent with the absence of LasR<sup>–</sup> phenotypes in evolved ∆<italic>cbrA</italic> or ∆<italic>cbrB</italic> cultures, Pool-Seq analysis found no mutations in <italic>lasR</italic> on either Day 4 or 6 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, pink and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) which was in striking contrast to the multiple LasR<sup>–</sup> alleles observed in wild type cultures. The absence of <italic>lasR</italic> mutations in the ∆<italic>cbrA</italic> and ∆<italic>cbrB</italic> derivatives was not due to differences in mutation frequency or number of generations as other mutations in distinct pathways under selection (e.g. <italic>fleR</italic> in <xref ref-type="fig" rid="fig2">Figure 2C</xref>) were present at comparable levels in all cultures (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for data). In addition, strain PA14 wild type and the ∆<italic>cbrA</italic> mutant had similar growth patterns as assessed by daily optical density measurements (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>). We also assessed a number of factors other than differential growth that could affect the rise of LasR<sup>–</sup> lineages. A previous report <xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref> found that LasR<sup>–</sup> strains in the PAO1 background undergo less severe alkaline-induced lysis in another complex medium (nutrient yeast broth) when grown aerobically, but we found no evidence of differential lysis in LB between wild-type and ∆<italic>lasR</italic> strains under our conditions (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Furthermore, buffering the medium to pH 7 suppressed medium alkalinization (from pH of 6.8–8.5) and lysis (<xref ref-type="bibr" rid="bib10">Crocker et al., 2019</xref>), but not the rise of LasR<sup>–</sup> lineages; though, the kinetics of LasR<sup>–</sup> lineage detection was delayed with buffering (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref> and <xref ref-type="bibr" rid="bib52">Sandoz et al., 2007</xref>). Lastly, to assess potential differences in toxicity of the wild type and ∆<italic>cbrB</italic> mutant culture supernatants toward LasR<sup>–</sup> cells through the production of secreted factors (<xref ref-type="bibr" rid="bib73">Yan et al., 2018</xref>), we grew the ∆<italic>lasR</italic> mutant in spent filtrate from wild-type and ∆<italic>cbrB</italic> cultures; no significant differences in colony forming units were observed (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2E</xref>).</p><p>The activation of CbrAB increases growth on diverse metabolites by inducing <italic>crcZ</italic> which sequesters Crc away from the targets that it translationally represses (<xref ref-type="fig" rid="fig2">Figure 2B</xref> for pathway). In D’Argenio et al. (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>), higher CbrB levels were observed in LasR<sup>–</sup> strains in a proteomics analysis, but no direct interactions between LasR and components of CbrA-CbrB-<italic>crcZ</italic>-Crc pathway have been described. Because CbrA, CbrB, and <italic>crcZ</italic> act to repress Crc, we hypothesized that if the loss of LasR function led to higher activity of the CbrA-CbrB-<italic>crcZ</italic> pathway and less Crc translational repression, we might also observe loss-of-function mutations in the genes encoding Crc or Hfq in the absence of <italic>cbrB</italic> (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Interestingly, the pooled genome sequence data from the Day 4 (open symbols) and Day 6 (grey symbols) populations evolved in the ∆<italic>cbrA</italic> and ∆<italic>cbrB</italic> backgrounds identified seven different mutations in <italic>crc</italic>, including three nonsense mutations, four missense mutations, and six indels, and these were among the most abundant mutations in the ∆<italic>cbrB</italic> mutant cultures; no <italic>crc</italic> mutations were identified in the PA14 wild type evolved populations (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). In ∆<italic>cbrB</italic>, <italic>crc</italic> mutant alleles showed the largest rise between Day 4 and Day 6 across all three replicate cultures (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). In the ∆<italic>cbrA</italic> passaged cultures, we also identified a rise in <italic>hfq</italic> mutations within the coding and upstream intergenic regions (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for sequence data) in addition to mutations in <italic>crc</italic>. The changes in relative abundances of alleles with mutations in <italic>crc</italic> and either the promoter or coding regions of <italic>hfq</italic> across the 2 days suggested that <italic>hfq</italic> mutations and <italic>crc</italic> mutations were in different backgrounds (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>To assess Crc-Hfq function in evolved strains, we leveraged Crc translational repression of the amidase AmiE, which cleaves the prototoxin FAA to the toxic FA (<xref ref-type="fig" rid="fig2">Figure 2D</xref> for pathway) (<xref ref-type="bibr" rid="bib45">O’Toole et al., 2000</xref>). Succinate, which downregulates CbrAB activity, maintains repression of AmiE, thereby enabling wild type to grow in the presence of FAA. In the absence of functional Crc or its co-repressor Hfq, cells synthesize AmiE, and FAA conversion into FA inhibits growth. As expected, on medium with succinate, FAA inhibited growth of the ∆<italic>crc</italic> mutant, but did not affect growth of the complemented ∆<italic>crc +crc</italic> strain, the wild type, and the ∆<italic>cbrA</italic> and <italic>∆cbrB</italic> mutants. However, in passaged ∆<italic>cbrA</italic> and <italic>∆cbrB</italic> cultures, spontaneous mutants in the population gave rise to larger colonies (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, top), and these isolates were FAA sensitive (<xref ref-type="fig" rid="fig2">Figure 2D</xref>) supporting the model that in the ∆<italic>cbrA</italic> and ∆<italic>cbrB</italic> backgrounds, mutations that abolished Crc or Hfq activity arose. Secondary mutants with FAA sensitivity also arose in the DH2417 ∆<italic>cbrB</italic> background upon passaging, indicating that this phenomenon was not unique to the PA14 background, and another study also reported <italic>crc</italic> and <italic>hfq</italic> mutants in the absence of <italic>cbrB</italic> (<xref ref-type="bibr" rid="bib5">Boyle et al., 2017</xref>). Given the apparent selection for decreased Crc function in ∆<italic>cbrA</italic> and <italic>∆cbrB</italic>, and the requirement of <italic>cbrA</italic> or <italic>cbrB</italic> for LasR<sup>–</sup> strain selection, we hypothesized that increased CbrAB activity may be a trait that increases the fitness of LasR<sup>–</sup> strains.</p><p>To complement the genetics approach of evolution assays in <italic>cbrAB</italic> mutants, we monitored the rise of LasR<sup>–</sup> lineages in LB medium supplemented with succinate, which inhibits CbrAB activity (<xref ref-type="bibr" rid="bib58">Sonnleitner et al., 2009</xref>). Medium amendment with 40 mM (pH 7) succinate was sufficient to repress CbrB-regulated <italic>crcZ</italic> small RNA expression in ∆<italic>lasR</italic> to levels reminiscent of ∆<italic>lasR∆cbrB</italic> (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). <italic>lasR</italic> mutants still responded to succinate; succinate reduced <italic>crcZ</italic> levels in ∆<italic>lasR</italic> and enabled ∆<italic>lasR</italic> growth on medium with FAA due to Crc activity (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, inset). This indicated that ∆<italic>lasR</italic> retains the Crc-Hfq mediated translational repression when succinate is present. Succinate amendment suppressed the rise of LasR<sup>–</sup> phenotypes in PA14 wild type (<xref ref-type="fig" rid="fig2">Figure 2F</xref>).</p></sec><sec id="s2-3"><title>Elevated <italic>cbrB</italic> and <italic>crcZ</italic> expression and reduced Crc-dependent repression are sufficient to recapitulate the growth advantages of LasR<sup>–</sup> strains</title><p>CbrAB activity induces the expression of <italic>crcZ</italic>, which sequesters Crc. We found that the ∆<italic>lasR</italic> mutant had ~two fold higher <italic>crcZ</italic> levels compared to wild type, suggesting higher activity of the CbrAB two- component system in LasR<sup>–</sup> strains (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Previous work reported higher yields on phenylalanine for LasR<sup>–</sup> relative to LasR<sup>+</sup> strains concomitant with elevated CbrB protein levels in a proteomics analysis (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>). Thus, we first used phenylalanine as a growth substrate to further dissect the activity of the CbrAB-<italic>crcZ</italic>-Crc pathway (<xref ref-type="fig" rid="fig2">Figure 2B</xref> for pathway) in LasR<sup>–</sup> strains. In planktonic cultures in medium with phenylalanine as a sole carbon source, the ∆<italic>lasR</italic> strain obtained significantly reduced lag (<xref ref-type="fig" rid="fig3">Figure 3B</xref>) and higher yields (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) than the wild type, and the enhanced growth phenotype was complementable by <italic>lasR</italic>. As previously reported, growth on phenylalanine depended on <italic>cbrB</italic>; the ∆<italic>cbrB</italic> and ∆<italic>lasR</italic>∆<italic>cbrB</italic> mutants grew similarly poorly and their growth yield could be fully complemented by expressing <italic>cbrB</italic> (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). Deletion of <italic>crc</italic> in the ∆<italic>lasR∆cbrB</italic> strain also restored growth to levels comparable to the ∆<italic>lasR</italic> and ∆<italic>lasR∆cbrB+cbrB</italic> strains (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>) indicating Crc repression of phenylalanine catabolism in the <italic>cbrB</italic> mutant. Overexpression of either <italic>cbrB</italic> or its target <italic>crcZ</italic>, which acts as a Crc-sequestering agent<italic>,</italic> was sufficient to improve yields on phenylalanine relative to the empty vector control (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Increased CbrB activity of LasR<sup>–</sup> strains is necessary and sufficient to promote growth on non-repressive substrates like phenylalanine via Crc.</title><p>(<bold>A</bold>) CbrB promotes the transcription of <italic>crcZ,</italic> and <italic>crcZ</italic> thus can be a readout of CbrB transcriptional activity. <italic>crcZ</italic> expression was measured by qRT-PCR relative to the average expression of the housekeeping genes <italic>rpoD</italic> and <italic>rpsL</italic> in cultures of PA14 WT and ∆<italic>lasR</italic> strains grown to OD<sub>600 nm</sub> = 1 from four independent experiments. *, p = 0.0334 as determined by Student’s paired two-tailed t-test. (<bold>B</bold>) Early growth (2 hr) and (<bold>C</bold>) Final yield (24 hr) on phenylalanine (Phe) as a sole carbon source shows enhanced growth for ∆<italic>lasR, cbrB</italic> dependence, and the requirement for <italic>cbrB</italic> is abolished by deletion of <italic>crc</italic>. Each point is the average of three replicates, repeated three independent days. Statistical significance determined by one-way ANOVA with Šídák’s multiple comparisons test. ns, not significant. *, p &lt; 0.05. **, p &lt; 0.005. ****, p &lt; 0.0001. (<bold>D</bold>) Final yield on Phe under (0.2%) arabinose-inducing conditions for the PA14 WT strain expressing an empty vector or <italic>crcZ</italic>, and <italic>cbrB</italic> overexpression constructs. Each point is the average of three replicates, performed on three separate days. Statistical significance determined by one-way ANOVA with multiple hypothesis correction as above.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title><italic>∆lasR</italic> strains have CbrB-dependent growth advantages that can be restored via loss of <italic>crc</italic>.</title><p>(<bold>A</bold>) Colony biofilm colony forming units (CFUs) were enumerated for strains PA14 WT, ∆<italic>lasR,</italic> ∆<italic>lasR</italic>∆<italic>cbrB,</italic> ∆<italic>lasR</italic>∆<italic>cbrB</italic>∆<italic>crc,</italic> ∆<italic>crc,</italic> and ∆<italic>cbrB</italic> after 16 hr on M63 minimal medium containing 0.2% phenylalanine, 20 mM mannitol, or 0.2% glucose, which have been well studied in the context of carbon catabolite repression (i.e. the CbrAB pathway) in addition to 10 mM citrate and 10 mM arginine. Bottom of y-axis set to starting inoculum density. P-values: ns, not significant; *, p &lt; 0.05; **, p &lt;; ***, p &lt; 0.0007; ****, p &lt; 0.0001 as determined by ordinary one-way ANOVA with Šídák’s multiple comparisons test. Each data point of colony count (CFU) was collected on a separate day (n = 6). (<bold>B</bold>). Early planktonic growth (2 hr post inoculation, top) and final yields on different carbon sources (bottom): 10 mM arginine (post 8 hr), 40 mM lactic acid (post 8 hr), and 10 mM citrate (post 7 hr). Each point displays the average growth (OD <sub>600 nm</sub>) across three independent experiments with three replicates per day. P-values: ns, not significant; *, p &lt; 0.05; **, p &lt;; ***, p &lt; 0.0007; ****, p &lt; 0.0001 as determined by ordinary one-way ANOVA with Šídák’s multiple comparisons test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig3-figsupp1-v2.tif"/></fig></fig-group><p>The CbrB- and Crc-controlled growth advantage on phenylalanine for LasR<sup>–</sup> strains in planktonic cultures was also apparent in colony biofilms (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). In colony biofilms, again, ∆<italic>lasR</italic> had improved growth on phenylalanine, that was dependent on <italic>cbrB</italic> and the growth defect of the <italic>lasRcbrB</italic> mutant could be rescued by deletion of <italic>crc</italic> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). The same pattern was observed on other substrates for which catabolism is under the control CbrAB-Crc pathway such as glucose and mannitol (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). While deletion of <italic>crc</italic> was able to restore enhanced growth to the ∆<italic>lasR</italic>∆<italic>cbrB</italic> mutant, ∆<italic>crc</italic> did not grow as robustly as the ∆<italic>lasR</italic> mutant which is consistent with the detection of LasR<sup>–</sup> lineages but not Crc<sup>–</sup> lineages in passaged wild type cultures. Thus, LasR<sup>–</sup> strains from stationary phase cultures appear to be primed for growth on multiple single carbon sources under CbrB-Crc control and reach higher final yields on these substrates.</p></sec><sec id="s2-4"><title>LasR<sup>–</sup> strains have CbrB-dependent growth advantages on metabolites enriched in progressive cystic fibrosis lung infections</title><p>Loss-of-function mutations in <italic>lasR</italic> are commonly detected in samples from chronic <italic>P. aeruginosa</italic> lung infections in pwCF, and these mutants have been correlated with a more rapid rate in lung function decline (<xref ref-type="bibr" rid="bib29">Hoffman et al., 2009</xref>). To determine the metabolite milieu in the CF lung, we performed a metabolomics analysis of bronchioalveolar lavage samples collected from 10 pwCF and 10 non-CF individuals (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The pwCF were infected with diverse pathogens and had varying lung function, which was measured as forced expiratory volume in 1 s and presented as the percent expected at one’s age (%FEV<sub>1</sub>). Over 300 compounds were measured, and no uniquely microbial metabolites were noted. Many compounds were higher in the CF population, but some were unchanged (e.g glucose) and others were higher in non-CF samples (e.g adenosine and glutathione as previously published <xref ref-type="bibr" rid="bib16">Esther et al., 2008</xref>; <xref ref-type="bibr" rid="bib21">Fitzpatrick et al., 2014</xref>; <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>In a principal component analysis (PCA), samples from non-CF individuals clustered together while those from pwCF were more spread. Samples from pwCF with high lung function (112 or 113 %FEV<sub>1</sub>) grouped among the non-CF samples (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The metabolites that contributed strongly to the first principal component, PC1, showed a significant inverse correlation with %FEV<sub>1</sub> including phenylalanine, arginine, lactate, and citrate (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). As with phenylalanine (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref> &amp; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>), the ∆<italic>lasR</italic> strain had growth advantages on arginine, lactate, and citrate that were controlled by CbrB and Crc (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>CbrB-dependent growth advantages may contribute to <italic>lasR</italic> mutant selection in distinct nutrient profiles of progressive cystic fibrosis airways.</title><p>(<bold>A</bold>) The first two dimensions (PC1 and PC2) of a principal component analysis of log normalized metabolite counts from bronchoalveolar lavage (BAL) samples collected from cystic fibrosis (CF, blue filled) and non-cystic fibrosis (non-CF, gray open) donors explain 62.84% and 15.08% of the variation in the data, respectively. PC1 separates the metabolite data by relative lung function as measured by percent forced expiratory volume in 1 s (%FEV<sub>1</sub>) for samples from people with CF. The %FEV<sub>1</sub> is overlayed for CF-donor samples with text. Samples from non-CF donors group more closely with CF-donor samples that have high lung function. (<bold>B</bold>) Spearman correlation analysis of the relative phenylalanine (orange), arginine (aqua), lactate (yellow), citrate (magenta), and adenosine (gray) metabolite counts in the BAL samples relative to %FEV<sub>1</sub> with exact p-values of 0.010, 0.005, 0.002, 0.041, and 0.714, respectively. Best fit semilog lines shown for visual clarity. (<bold>C</bold>) Comparison of the final yield measured after 24 hr for strains PA14 wild type and ∆<italic>lasR</italic> across a subset of carbon sources in BIOLOG growth assays for which the metabolite was found to be in higher abundance in CF-donor relative to non-CF donor BAL samples. Bold font indicates carbon sources analyzed in <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. Number in parenthesis refers to the ratio of the average counts for each metabolite in CF relative to non-CF samples. **, p-value = 0.003 as determined by two-tailed paired t-test comparing growth across CF-enriched metabolites between the wild type and ∆<italic>lasR</italic> strains. Succinate (gray diamond, black dashed line) was not detected (nd) in the BAL samples and thus not included in the statistical analysis, but the growth data is shown for reference. (<bold>D</bold>) Observed percentage of colonies with LasR<sup>–</sup> phenotypes over the course of evolution from strains (top) PA14 WT or (bottom) CF isolate (both green circles) with ∆<italic>cbrB</italic> (purple squares) derivatives in artificial sputum medium (ASM), which was designed to recapitulate the CF lung nutritional profile. ns, not significant (p-value &gt; 0.9); ***, p = 0.0008; ****, p &lt; 0.0001 as determined by ordinary two-way ANOVA with Šídák’s multiple comparisons test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Quantitative amino acid analysis.</title><p>(<bold>A</bold>) The first two components (PC1 and PC2) of a principal component analysis of log normalized amino acid concentrations measured in bronchoalveolar lavage (BAL) fluid collected from cystic fibrosis (CF, blue filled circles) and non-cystic fibrosis (Non-CF, black open circles) donors by the Biocrates AbsoluteIDQ p180 Kit explain 91.62% and 6.14% of the variation in the data, respectively. As with the relative metabolite counts measured by LC/MS used in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, PC1 of the amino concentrations measured by the Biocrates AbsoluteIDQ p180 Kit separates BAL samples by the respective percent forced expiratory volume in 1 s (%FEV<sub>1</sub>) (overlayed text). (<bold>B</bold>) Average amino acid concentrations (µM) measured from BAL samples collected from cystic fibrosis (CF, blue) and non-cystic fibrosis (Non-CF, black) donors. See <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> for data by sample.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig4-figsupp1-v2.tif"/></fig></fig-group><p>We identified the 20 carbon sources that were most enriched in CF samples including those that correlated inversely with lung function, then used a BIOLOG phenotype array to assess whether the trend of greater yield for the ∆<italic>lasR</italic> strain persisted across this set. We found a significantly higher yield for the ∆<italic>lasR</italic> strain when we analyzed growth of the WT and ∆<italic>lasR</italic> across this group of 20 carbon sources suggesting that ∆<italic>lasR</italic> has improved growth on many of the nutrients available in the lung (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><p>To further test the hypothesis that the growth phenotypes of LasR<sup>–</sup> strains can promote selection in the nutrient environment of the CF lung, we performed evolution experiments using both strain PA14 and a LasR<sup>+</sup> CF clinical isolate in a medium designed to more closely recapitulate the nutritional profile of the cystic fibrosis airway. Upon absolute quantitation, we observed good concordance between the relative abundances of amino acids found in BAL fluid and reported for sputum (<xref ref-type="bibr" rid="bib46">Palmer et al., 2005</xref>) which served as a basis for an artificial sputum medium, ASM (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>; <xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>) that was based on a previously reported synthetic CF medium (SCFM2) (<xref ref-type="bibr" rid="bib46">Palmer et al., 2005</xref>). LasR<sup>–</sup> strains evolved in both strain backgrounds (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) with kinetics similar to what was observed in LB medium (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Parallel evolution experiments in ASM initiated with ∆<italic>cbrB</italic> derivatives did not exhibit a rise in LasR<sup>–</sup> phenotypes in either strain background to suggest that CbrAB activity was again a contributor to the fitness of <italic>lasR </italic>LOF mutants.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Through mathematical modeling, experimental evolution, and competition assays, we found that the rise of problematic <italic>P. aeruginosa</italic> LasR<sup>–</sup> variants frequently observed in disease could be explained by increases in yield and decreases in lag during growth on carbon sources abundant in the lung environment (<xref ref-type="fig" rid="fig5">Figure 5</xref>). In fact, the steady state growth rate for ∆<italic>lasR</italic> was slightly less than that for the wild type, which is consistent with the model that there are frequently tradeoffs between a shorter lag phase and overall growth rate (<xref ref-type="bibr" rid="bib2">Basan et al., 2020</xref>). Interestingly, CF-adapted <italic>P. aeruginosa</italic> isolates have been found to have slower in vitro growth rates than other strains (<xref ref-type="bibr" rid="bib74">Yang et al., 2008</xref>). Other factors will impact the relative fitness of LasR<sup>+</sup> and LasR<sup>–</sup> cells across different growth phases (<xref ref-type="fig" rid="fig5">Figure 5</xref>) including oxygen availability and pH buffering capacity, which may lead to differential lysis (<xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>), or the need for (or exploitation of) proteases to gain access to growth substrates (<xref ref-type="bibr" rid="bib62">Van Delden et al., 1998</xref>; <xref ref-type="bibr" rid="bib52">Sandoz et al., 2007</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>CbrAB activity contributes to the positive selection of LasR<sup>–</sup> strains in complex media.</title><p>LasR<sup>–</sup> strain fitness relative to wild type is shown across growth phases, including lag, exponential growth, stationary, and death phases. Relative fitness of the LasR<sup>–</sup> strain (dotted black line) is calculated from the experimentally determined monoculture growth data of strains PA14 wild type (WT) and ∆<italic>lasR</italic> over time. Values above one indicate a LasR<sup>–</sup> strain fitness advantage over the WT strain during that growth phase. Circled insets show representative cartoons of LasR- (beige) and LasR+ (green) cells at each growth phase to indicate dividing or lysing cells (burst cells) across growth stages. The heights of the peaks or valleys of the relative fitness lines can be altered by several modulating factors including those that contribute to the positive and negative selection of LasR<sup>–</sup> strains. Other modulating factors reported or suggested in the literature include inter- and intra- species competition, extracellular protease, immunoclearance, and oxygenation which are likely condition dependent. In the absence of CbrA or CbrB (CbrAB-, dotted purple line) or in the presence of succinate (one CbrAB repressive substrate), the relative growth of LasR<sup>–</sup> strains is lower resulting in a reduction in the observed selection. This could be partially relieved in the CbrAB- background through disruption of Crc or Hfq function (blue dotted line), restoring activity through the pathway.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-76555-fig5-v2.tif"/></fig><p>The overlap between the model-predicted and observed percentages of LasR<sup>–</sup> strains over the course of the evolution regime suggests that the described social advantage resulting from QS dysfunction for LasR<sup>–</sup> strains (i.e. social cheating) is not necessary to explain the timing and kinetics of the initial rise of LasR<sup>–</sup> strains under our conditions. However, social interactions that benefit LasR- strains may be evident where the model estimates percentages that fall below or on the lower range of that experimentally observed, such as Day 4 or 6. A more detailed discussion of when social interactions are required is found below.</p><p>The data presented support the model that that increased growth of LasR<sup>–</sup> cells on many amino acids, sugars, and lactate is due to higher CbrAB-controlled <italic>crcZ</italic> levels which downregulates metabolism under Crc control, and these findings nicely parallel studies by D’Argenio et al. (<xref ref-type="bibr" rid="bib15">D’Argenio et al., 2007</xref>) that found higher levels of CbrB in LasR<sup>–</sup> isolates. In PA14 ∆<italic>cbrA</italic> and ∆<italic>cbrB</italic> mutants, <italic>lasR </italic>LOF mutations did not arise, but mutations in <italic>crc</italic> and upstream of <italic>hfq</italic> were observed. As <italic>crc</italic> mutations phenocopy some of the growth advantages of the <italic>lasR</italic> mutants (<xref ref-type="fig" rid="fig2">Figures 2C</xref> and <xref ref-type="fig" rid="fig3">3</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>), the importance of derepressed catabolism for fitness is underscored. It is interesting to note that there were differences in the relative dependence on CbrB for the selection for LasR<sup>–</sup> between strains PA14 and DH2417, and in ASM the dependence on <italic>cbrB</italic> for the selection of LasR<sup>–</sup> strains increased in both strains (<xref ref-type="fig" rid="fig4">Figure 4D</xref>) suggesting that different environments may alter the importance of different LasR- and CbrB-controlled targets important for fitness that have yet to be elucidated. Though deletion of <italic>cbrA</italic> or <italic>cbrB</italic> can have pleiotropic effects (<xref ref-type="bibr" rid="bib75">Yeung et al., 2011</xref>), we did not observe differences in density, quorum sensing regulation, production of quorum sensing controlled factors such as proteases, lysis in stationary phase, or overall mutation accumulation between wild type, ∆<italic>cbrA</italic>, and ∆<italic>cbrB</italic> that could explain differences in the rise of LasR<sup>–</sup> subpopulations. Furthermore, environmental modification of CbrB activity by the addition of succinate to LB (<xref ref-type="bibr" rid="bib58">Sonnleitner et al., 2009</xref>) also suppressed the emergence of LasR<sup>–</sup> strains in the wild type. Because CbrAB activity can still be suppressed by succinate in LasR<sup>–</sup> cells (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), LasR<sup>–</sup> variants were not strictly ‘de-repressed’, and this is consistent with the fact that ∆<italic>lasR</italic> and ∆<italic>crc</italic> growth patterns were not identical. Unlike <italic>lasR</italic> mutations, <italic>crc</italic> mutations are not commonly observed in clinical isolates (<xref ref-type="bibr" rid="bib70">Winstanley et al., 2016</xref>) and <italic>crc</italic> mutants have been shown to be under negative selection in Tn-Seq experiments (<xref ref-type="bibr" rid="bib34">Lorenz et al., 2019</xref>).</p><p>Analysis of BAL fluid revealed higher levels of substrates such as lactate and amino acids, which require CbrB for consumption, in samples from pwCF, and these findings are consistent with other more targeted analyses of CF airway samples (<xref ref-type="bibr" rid="bib3">Bensel et al., 2011</xref>; <xref ref-type="bibr" rid="bib61">Twomey et al., 2013</xref>). Consistent with our finding that higher levels of certain metabolites correlated with worse CF lung disease, other studies including that of <xref ref-type="bibr" rid="bib17">Esther et al., 2016</xref> found a correlation between total metabolites and neutrophil counts suggesting host cell lysis, along with lysis of microbial cells, may be a major contributor to a shift in the metabolome. CF-lung derived <italic>P. aeruginosa</italic> isolates can have amino acid auxotrophies and enhanced amino acid uptake (<xref ref-type="bibr" rid="bib32">La Rosa et al., 2019</xref>) which supports ready access to amino acids in vivo. Several CF isolates show reduced succinate assimilation to suggest the uptake of less preferred substrates over the course of adaptation, which may indicate decreased Crc activity over time (<xref ref-type="bibr" rid="bib30">Jørgensen et al., 2015</xref>; <xref ref-type="bibr" rid="bib31">La Rosa et al., 2018</xref>).</p><p>Our model predicts LasR<sup>–</sup> strains benefit from growth advantages that might be present when new nutrients become available (analogous to lag phase) and in dense populations when improved yields for the ∆<italic>lasR</italic> mutant emerges; due to a slower steady state growth rate, we predict that LasR<sup>–</sup> strains would not emerge under steady state growth conditions such as in a chemostat. Indeed, the advantages of decreased lag phase in cultures has been proposed to be a universal adaptation in dynamic environments (<xref ref-type="bibr" rid="bib2">Basan et al., 2020</xref>; <xref ref-type="bibr" rid="bib4">Bertrand and Margolin, 2019</xref>). Thus, the frequent emergence of LasR<sup>–</sup> lineages in the CF lung and other disease settings suggests that <italic>P. aeruginosa</italic> often undergoes growth transitions in vivo, possibly due to fluctuating local conditions, spatial heterogeneity, or the result of complex competition between bacterial and host cell types. The CbrB-dependent rise of LasR<sup>–</sup> strains in the complex CF mimetic medium (i.e. artificial sputum medium, ASM) alongside the positive selection observed in minimal media with CF relevant substrates (<xref ref-type="bibr" rid="bib55">Scribner et al., 2022</xref>) shown to require CbrB for LasR<sup>–</sup> strain growth enhancement suggests that the growth advantages of <italic>lasR</italic> mutants may be sufficient to overcome any potential negative selective pressures mediated by the host, neighboring microbes, or inaccessibility to nutrients like complex protein or adenosine. In addition, the loss of LasR function enables other inherent advantages that contribute to competitive fitness including resistance to lysis under conditions of high aeration, enhanced microoxic fitness, enhanced RhlR activity (<xref ref-type="bibr" rid="bib7">Chen et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>; <xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>), and altered intraspecies interactions (<xref ref-type="bibr" rid="bib39">Mould et al., 2020</xref>) which may be relevant in the complex and dynamic nutritional environment of the CF airway over the course of disease. The connection between these phenotypes and the CbrAB-<italic>crcZ</italic>-Crc pathway is not yet clear.</p><p>The increased growth in post-exponential phase cultures for LasR<sup>–</sup> strains bears similarities to mutations that arise in other microbes. For example, the selection for <italic>rpoS</italic> mutants in stationary phase cultures of <italic>E. coli</italic> (<xref ref-type="bibr" rid="bib20">Finkel and Kolter, 1999</xref>; <xref ref-type="bibr" rid="bib76">Zambrano et al., 1993</xref>; <xref ref-type="bibr" rid="bib78">Zinser and Kolter, 2000</xref>) is also dependent on nutrient accessibility (<xref ref-type="bibr" rid="bib18">Farrell and Finkel, 2003</xref>) with enhanced amino acid catabolism as a major contributor to <italic>E. coli</italic> lineages with growth advantages in stationary phase (GASP) (<xref ref-type="bibr" rid="bib77">Zinser and Kolter, 1999</xref>). While the rise of <italic>rpoS</italic> mutants in laboratory settings required pH-driven lysis (<xref ref-type="bibr" rid="bib18">Farrell and Finkel, 2003</xref>), LasR<sup>–</sup> strains still evolved in buffered medium suggesting distinct mechanisms for the metabolic advantages of <italic>lasR</italic> mutants. It is worth noting that none of the common GASP mutations (<italic>rpoS, lrp</italic>, or <italic>ybeJ-gltJKL</italic>) were identified in our in vitro evolution studies (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We considered that the enhanced growth of LasR<sup>–</sup> strains in post-exponential growth phases may be due to differences in ppGpp signaling, given growth arrest as part of the stringent response modifies the expression of QS-regulated genes (<xref ref-type="bibr" rid="bib63">van Delden et al., 2001</xref>). However, no mutations in <italic>relA</italic> or <italic>spoT</italic>, the two ppGpp synthases, were observed. The mechanism of increased CbrB activity in ∆<italic>lasR</italic> remains an unresolved question that is relevant to <italic>P. aeruginosa</italic> biology and may aid in the identification of the signals that activate the CbrA sensor kinase which influences clinically relevant phenotypes including virulence and antibiotic resistance (<xref ref-type="bibr" rid="bib75">Yeung et al., 2011</xref>). Our working model is that the upregulation of CbrB transcription of <italic>crcZ</italic> increases levels of transporters and catabolic enzymes due to the release from Crc repression, and this enhanced substrate uptake alters intracellular metabolite pools driving metabolism in accordance with Le Chatelier’s principle (<xref ref-type="bibr" rid="bib38">Monod, 1949</xref>). Thus, quorum sensing mutants can maintain higher growth rates at lower substrate concentrations than for quorum-sensing intact cells.</p><p>The repeated observation that LOF mutations readily arise in diverse settings provokes the question of how quorum sensing is maintained. Several elegant mechanisms that address this point have been described. First, the wiring of the LasR regulon is such that while there are growth advantages on many substrates present in the lung, there are growth disadvantages on other important nutrient sources (e.g. adenosine and proteins and peptides <xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>). Social cheating can promote the rise of LOF mutants in protease-requiring environments (<xref ref-type="bibr" rid="bib14">Diggle et al., 2007</xref>; <xref ref-type="bibr" rid="bib27">Hassett et al., 1999</xref>). Second, there are quorum-sensing controlled ‘policing’ mechanisms through which LasR<sup>+</sup> strains restrict the growth of LasR<sup>–</sup> types through the release of products toxic to quorum-sensing mutants (<xref ref-type="bibr" rid="bib6">Castañeda-Tamez et al., 2018</xref>; <xref ref-type="bibr" rid="bib23">García-Contreras et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Wang et al., 2015</xref>). Lastly, there are other tradeoffs such as sensitivity to oxidative stress that may limit LasR<sup>–</sup> lineage success (<xref ref-type="bibr" rid="bib27">Hassett et al., 1999</xref>). Quorum sensing exerts metabolic control in other diverse microbes beyond <italic>P. aeruginosa</italic>. Thus, these data provide insight into generalizable explanations for the benefits of metabolic control in dense populations and indicate drivers for frequent loss-of-function mutations in quorum-sensing genes such as <italic>agr</italic> in <italic>Staphylococcus aureus</italic> and <italic>hapR</italic> in <italic>Vibrio cholerae</italic> (<xref ref-type="bibr" rid="bib40">Mould and Hogan, 2021</xref>).</p><p>Together, these data highlight the power of coupling in vitro evolution studies with forward and reverse genetic analyses. Other benefits to this approach include the ability to dissect subtle differences between pathway components. For example, multiple mutations in <italic>crc</italic> repeatedly rose in ∆<italic>cbrA-</italic>, but not in ∆<italic>cbrB</italic>-derived populations, and multiple mutations in <italic>hfq</italic> rose in ∆<italic>cbrB</italic>-, and not in ∆<italic>cbrA</italic>-derived populations. While CbrA and B work together as do Crc and Hfq, these observations may provide a foothold into key distinctions that could yield mechanistic insights. In the future, the ability for deep sequencing of infection populations and analysis of evolutionary trajectories may aid diagnoses and treatment decisions in beneficial ways.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><p>See Key Resources Table in supplement for additional details on key reagents.</p><sec id="s4-1"><title>Strain construction and maintenance</title><p>In-frame deletions and complementation constructs were made using a <italic>Saccharomyces cerevisiae</italic> recombination technique described previously (<xref ref-type="bibr" rid="bib56">Shanks et al., 2006</xref>). The <italic>cbrB</italic> and <italic>crcZ</italic> expression vectors were constructed by HiFi Gibson assembly with the NEBuilder HiFi DNA Assembly kit according to manufacturer’s protocol. All plasmids were sequenced at the Molecular Biology Core at the Geisel School of Medicine at Dartmouth. In frame-deletion and complementation constructs were introduced into <italic>P. aeruginosa</italic> by conjugation via S17/lambda pir <italic>E. coli</italic>. Merodiploids were selected by drug resistance and double recombinants were obtained using sucrose counter-selection and genotype screening by PCR. Expression vectors were introduced into <italic>P. aeruginosa</italic> by electroporation and drug selection. All strains used in this study are listed in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. Bacteria were maintained on lysogeny broth (LB) with 1.5% agar. Yeast strains for cloning were maintained on YPD (yeast extract-peptone-dextrose) with 2% agar. Artificial sputum medium (ASM) was made as described previously (<xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>).</p></sec><sec id="s4-2"><title>Mathematical model</title><p>Growth parameters were determined from 5 mL grown LB cultures inoculated as described in the experimental evolution protocol and the monocarbon growth below. In brief, a 16 h overnight LB culture was normalized to OD<sub>600 nm</sub> = 1 in LB, and a 250 µL aliquot of the normalized culture was used to inoculate 5 mL fresh LB for an approximate OD<sub>600 nm</sub> = 0.05 at time zero. The density (OD<sub>600 nm</sub>) was measured for up to 48 hr by taking a 10–100 µL aliquot at the designated time intervals from the 5 mL culture tube with dilution into LB as appropriate in a 96-well plate (100 µL total per well) for OD<sub>600 nm</sub> measurement using a Spectramax M2 microplate reader with Softmax Pro 6.5.1 software. Lag and growth rate were measured in separate experiments from those used to monitor lysis so that the volume in the 5 mL cultures tubes never dropped below 10% of the starting volume. See <xref ref-type="supplementary-material" rid="supp7">Supplementary file 7</xref> for additional details for the parameter choices used in the mathematical model and <xref ref-type="supplementary-material" rid="scode1">Source code 1</xref> for the Matlab script.</p></sec><sec id="s4-3"><title>Experimental evolution</title><p>Experimental evolution was modeled after work by <xref ref-type="bibr" rid="bib28">Heurlier et al., 2005</xref>. A single colony of each strain was used to inoculate a 5 mL LB culture in 13 mm borosilicate tubes. The tubes inoculated with a single colony were grown for 24 hr at 37 °C on a roller drum. The 24 hr grown culture was adjusted to OD<sub>600 nm</sub> = 1 in LB based on OD<sub>600 nm</sub> reading of a 1–10 dilution in LB of the 24 hr culture in a 1 cm cuvette using a Spectronic GENESYS 6 spectrophotometer. Separate 250 µL aliquots of the OD<sub>600 nm</sub> normalized cells was sub-cultured into three tubes containing 5 mL fresh media to initiate the evolution experiment (i.e. time 0) with three distinct replicate cultures per experiment. At time of passage every two days, 25 µL of culture was transferred into 5 mL fresh media. Every day (or as indicated) cultures were diluted and spread onto LB agar plates using sterile glass beads for phenotype distinction. The LB agar plates were incubated for ~ 24 hr at 37 °C and then left at room temperature for phenotype development. The sheen LasR<sup>–</sup> colony morphologies were counted, and the percentage of LasR<sup>–</sup> phenotypes calculated based on total CFUs. All experimental evolutions in LB were repeated on at least three independent days with three replicates of each strain per experiment unless otherwise stated. The ASM and succinate amended medium evolutions were completed on two separate days. In the case of ∆<italic>rhlR</italic> and <italic>∆anr</italic>, the three replicates were inoculated from three independent overnights. Data visualization and statistical analysis was performed in GraphPad Prism 9 (version 9.2.0).</p></sec><sec id="s4-4"><title>gDNA extraction, sequencing, SNP calling of Pool-Seq data</title><p>Between 100 and 150 random colonies were scraped and pooled from the LB agar plates that were counted and used to measure the percent of colonies with LasR<sup>–</sup> phenotypes at Days 4 and 6 from a representative WT-, ∆<italic>crbA-</italic>, and ∆<italic>cbrB-</italic>initiated evolution experiment. For plates containing a total of 100–150 colonies, all colonies on the plate were collected for a single pooled genomic DNA extraction. If more than 150 colonies were on a plate, the plate was divided equally, and all colonies in an arbitrary section were collected to ensure genomic DNA was extracted from a similar number of colonies for each sample. Scraped up cells were pelleted briefly in a 1.5 mL Eppendorf tube via a short spin, resuspended in 1 mL PBS, vortexed briefly, and gDNA was subsequently extracted from a 50 µL aliquot of cell resuspension via the Master Pure Yeast DNA purification kit according to manufacturer’s protocol with RNAase treatment. A 2.5 µg aliquot was submitted for Illumina sequencing (1Gbp) at the Microbial Genome Sequencing (MiGs) Center on the NextSeq 2000 platform. The resulting forward and reverse reads were trimmed with bcl2fastq (v2.20.0422) to remove Illumina adaptor sequences during the demultiplexing process. Both forward and reverse read files were aligned and compared to the complete and annotated UCBPP-PA14 genome available on NCBI (accession GCF_000014625.1) using the variant caller BreSeq (<xref ref-type="bibr" rid="bib12">Deatherage and Barrick, 2014</xref>) (version 0.35.4) with the -p option for polymorphisms and a 5% cutoff. Specifically, the following command was used: breseq -p -j 10 r [reference file] [sample name]_.fastq.gz [sample name]_fastq.gz -o [output file name]. This provided an output file that specified variations from the reference genome and listed their respective fractions of the total reads. These fractions were treated as estimations of genotype proportions in the population. Variants at fixation (100%) across all 18 samples (three strains, 2 days) were excluded from follow-up analysis as potential differences in strain background that differed from the reference genome at the start of the experiment. All sequencing data is available on the Sequence Read Archive with the accession number PRJNA786588.</p></sec><sec id="s4-5"><title>Milk proteolysis</title><p>Brain Heart Infusion Agar was supplemented with powdered skim milk dissolved in water to a final concentration of 1%. The evolved isolates selected on basis of ‘sheen’ colony morphology were grown in a 96-well plate with 200 µL LB per well for 16 hr. Milk plates were inoculated with ~ 5 µL of culture using a sterilized metal multiprong inoculation device (Dan-Kar) and incubated at 37 °C for 16 hr. PA14 WT and ∆<italic>lasR</italic> strains were included as controls. Colonies which showed a halo of clearing larger than the ∆<italic>lasR</italic> control strain were considered protease positive.</p></sec><sec id="s4-6"><title>Acyl homoserine lactone autoinducer bioreporter assays</title><p>Protocol as described in <xref ref-type="bibr" rid="bib39">Mould et al., 2020</xref>. Briefly, 100 µL of OD<sub>600 nm</sub> normalized LB overnight cultures (OD<sub>600 nm</sub> = 0.01) of the AHL-synthesis deficient reporter strains DH161 (3OC12HSL-specific) or DH162 (3OC12HSL or C4HSL responsive) with AHL-responsive promoters to <italic>lacZ</italic> (<xref ref-type="bibr" rid="bib68">Whiteley and Greenberg, 2001</xref>; <xref ref-type="bibr" rid="bib67">Whiteley et al., 1999</xref>) were bead spread on LB plates containing 150 µg/mL 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (XGAL, dissolved in DMSO). Inoculated plates were allowed to dry 10 min in a sterile hood. Once dry, 5 µL of either the test strains or control cultures (PA14 wild type and ∆<italic>lasR</italic> strains) were spotted onto the inoculated reporter lawns. After the spots dried, plates were incubated at 37 °C for 16 hr then stored at 4 °C to allow for further color development, if necessary, based on wild-type colony activity. The blue halo that formed around the colony was interpreted as AHL activity. The levels of AHL produced are approximated by the size of the blue halo formed around the colony.</p></sec><sec id="s4-7"><title>Competition assays</title><p>Competition assays were performed by competing strains against an <italic>att::lacZ</italic> strain as previously reported (<xref ref-type="bibr" rid="bib8">Clay et al., 2020</xref>). Overnight cultures of <italic>att::lacZ</italic> competitor and test strains were normalized to OD<sub>600 nm</sub> = 1 and mixed in the designated ratios with either a wild type control or ∆<italic>lasR</italic> strain. Aliquots of 10<sup>–6</sup> dilutions of the initial mixed inoculums were immediately plated on LB plates containing 150 µg/mL XGAL by spreading an aliquot of 25–50 µL with sterilized glass beads. Roughly 100–200 colonies were counted to determine the initial ratios of PA14 <italic>att:lacZ</italic> to ∆<italic>lasR</italic> or the WT control strains by blue:white colony phenotype, respectively. To begin the competition experiment, a 250 µL aliquot of each undiluted mixed inoculum was sub-cultured into 5 mL fresh LB medium and incubated on a roller drum at 37 °C for 6 hr. After 6 hr, the cultures were collected, diluted by 10<sup>–6</sup> in fresh liquid LB, and plated as previously stated for blue:white colony screening. The LB plates containing XGAL were incubated overnight at 37 °C prior to counting. Competitions were repeated on three separate days.</p></sec><sec id="s4-8"><title>Kinase mutant evolution screen</title><p>Using an ethanol/flame sterilized metal multiprong inoculation device (Dan-Kar), the kinase mutant library (<xref ref-type="bibr" rid="bib65">Wang et al., 2021</xref>) was inoculated into a 96-well plate with 200 µL LB per well for 24 hr shaking at 37 °C. The 24 hr grown cultures were used to inoculate two 96-well plates with each kinase mutant (including PA14 WT control) in triplicate. These cultures were grown for 48 hr upon which 2 µL was transferred to new 96 well plates with fresh 200 µL LB liquid per well. Every 2 days, the wells containing the wild-type replicates were diluted by 10<sup>–6</sup> in fresh LB and 25 µL was bead spread onto LB for phenotypic distinction based on sheen colony morphology. At Day 14, when all wildtype replicates contained at least 50% LasR<sup>–</sup> phenotypes, all wells were diluted and plated as stated previously for determination of sheen colony morphology. A secondary screen in 5 mL LB (as described above in Experimental Evolution section) was initiated with those mutant strains which did not show any LasR<sup>–</sup> phenotypes across all three replicates in the microtiter assay at Day 14. The Circos plot summarizing the screen data was generated using BioCircos (<xref ref-type="bibr" rid="bib11">Cui et al., 2016</xref>) in R (version 4.0.2) and re-colored in Adobe Illustrator.</p></sec><sec id="s4-9"><title>Filtrate toxicity</title><p>Based on a protocol used previously (<xref ref-type="bibr" rid="bib1">Abisado et al., 2021</xref>), strains were grown 16 hr in LB (5 mL) on a roller drum at 37 °C, centrifuged at 13 K RPM for 10 min in 2 mL aliquots, and the resulting supernatant was filter sterilized through a 0.22 µm pore filter. Per 5 mL filtrate, 250 µL of fresh LB was added. A 16 hr, grown LB culture (5 mL) of PA14 ∆<italic>lasR</italic> was normalized to an OD<sub>600 nm</sub> = 1 in LB, and 250 µL was used to inoculate 5 mL of the filtrate-LB mixture. The ∆<italic>lasR</italic> cultures were grown for 24 hr at 37 °C on the roller drum upon which colony counts were determined by bead spreading an appropriate dilution on LB plates. Data visualization and statistical analysis were performed in GraphPad Prism 9 (version 9.2.0).</p></sec><sec id="s4-10"><title>Fluoroacetamide sensitivity assay</title><p>Strains were inoculated (either by patching from plates or by spotting 5 µL of 16 h LB grown culture) onto plates containing 1.5% agar with M63 salts,10 mM lactamide, and 40 mM succinate with or without 2.5 mg/mL filter-sterilized fluoroacetamide (FAA) dissolved in water based on protocol by <xref ref-type="bibr" rid="bib9">Collier et al., 2001</xref>. Relative growth was compared in the presence and absence of FAA. PA14 wild type and ∆<italic>crc</italic> were included as controls in every experiment wherein wild type displays robust growth on FAA in the presence of succinate and the ∆<italic>crc</italic> strain, little to none.</p></sec><sec id="s4-11"><title>Quantitative RT-PCR</title><p>The indicated strains were grown from single colonies in 5 mL LB cultures on a roller drum for 16 hr, normalized to an OD<sub>600 nm</sub> of 1, and 250 µL of normalized culture was inoculated into 5 mL fresh LB for a starting inoculum around OD<sub>600 nm</sub> = 0.05. The cultures were then grown at 37 °C on a roller drum until OD<sub>600 nm</sub> = 1 at which point a 1 mL aliquot of culture was pelleted by centrifugation for 10 min at 13 K RPM. Supernatant was removed, and the cell pellets were flash frozen in an ethanol dry ice bath. This was repeated on three separate days with one WT and one ∆<italic>lasR</italic> culture pair (n = 4) collected on each day or one ∆<italic>lasR</italic> and one ∆<italic>lasR∆cbrB</italic> culture pair (n = 3) each day. Pellets were stored at –80 °C until all sets of pellets were collected. RNA was extracted using the QIAGEN RNAeasy kit according to the manufacturer’s protocol, and 7 μg RNA was twice DNAse treated with the Turbo DNA-free kit (Invitrogen). DNA contamination was checked by semi-quantitative PCR with gDNA standard for 35 cycles with <italic>rpoD</italic> qRT primers; if DNA contamination was greater than 0.004 ng / μL, the sample was DNAse treated again. cDNA was synthesized from 400  ng of DNase-treated RNA using the RevertAid H Minus first-strand cDNA synthesis kit (Thermo Scientific), according to the manufacturer’s instructions for random hexamer primer (IDT) and a GC-rich template alongside an NRT control. Quantitative RT-PCR was performed on a CFX96 real-time system (Bio-Rad), using SsoFast Evergreen supermix (Bio-Rad) according to the following program: 95 °C for 30 s and 40 cycles of 95 °C for 5 s and 60 °C for 5 s followed by a melt curve with 65 °C for 3 s up to 95 °C in increments of 0.5 °C. Transcripts were normalized to the average <italic>rpoD</italic> and <italic>rpsL</italic> expression unless stated otherwise. <italic>rpsL</italic> and <italic>crcZ</italic> primers as designed in <xref ref-type="bibr" rid="bib72">Xia et al., 2020</xref>. <italic>rpoD</italic> primers as designed in <xref ref-type="bibr" rid="bib26">Harty et al., 2019</xref>. Data visualization and statistical analysis performed in GraphPad Prism 9 (version 9.2.0).</p></sec><sec id="s4-12"><title>Mono-carbon growth</title><p>Single carbon sources were supplemented into M63 base (<xref ref-type="bibr" rid="bib41">Neidhardt et al., 1974</xref>) and filter sterilized. A 16 hr overnight LB culture grown at 37 °C on a roller drum was normalized to an OD<sub>600 nm</sub> = 1 in 2 mL LB. For liquid growth curves, a 250 µL aliquot of the density adjusted culture was spiked into 5 mL fresh M63 medium with designated carbon source in triplicate, and growth was monitored using a Spectronic 20D+ (Spec20) hourly in 13 mm borosilicate tubes. Every point on the growth plots is the average of three replicates per day, repeated 3 days total. For colony biofilm growth, 5 µL of OD<sub>600 nm</sub> = 1 normalized culture was inoculated onto 1.5% agar plate of M63 medium containing the designated carbon source in singlicate and grown for 16 hr at 37 °C. Colonies were cored using the back of a P1000 tip and disrupted by 5 min on Genie Disrupter in 1 mL LB. Disrupted colony biofilms were serially diluted. 5 µL of the serial dilutions were plated and a 50 µL aliquot of diluted colony resuspension (10<sup>–6</sup> or 10<sup>–7</sup>-fold, depending on condition/strain) was bead spread and counted for colony forming units. Colony biofilm growth was assessed on &gt;5 independent days. Data visualization and statistical analysis performed in GraphPad Prism 9 (version 9.2.0).</p></sec><sec id="s4-13"><title>Metabolomics of bronchioloalveolar lavage fluid and artificial sputum medium</title><p>Human samples from people with and without cystic fibrosis were obtained with informed consent following institutional review board-approved protocols at Geisel School of Medicine at Dartmouth. The investigators were blinded to the conditions of the experiments during data collection and analysis. To obtain relative metabolite counts, bronchioloalveolar lavage (BAL) fluid samples were briefly centrifuged to exclude large debri then the supernatant was flash frozen in liquid nitrogen. Samples were processed by Metabolon via LC/MS for relative metabolite amounts. Raw values from Metabolon were normalized to protein concentrations by the BioRad Bradford protein concentration or raw area counts per day sample run and then the values were rescaled to set the median to one. Missing values were imputed with the minimum rescaled value for that biochemical. Quantitative amino acid concentrations were determined for aliquots of the same BAL samples (lyophilized) using the Biocrates AbsoluteIDQ p180 kit at the Duke Proteomics Core Facility. The lyophilized samples of BAL were homogenized in water and 50/50 water/methanol respectively to extract metabolites. 25 µL of the BAL extract were utilized for preparation of the samples on a Biocrates AbsoluteIDQ p180 plate. A Waters Xevo-TQ-S mass spectrometer was utilized to acquire targeted metabolite quantification on all samples and quality control specimens. Raw data (in µM) was exported independently for the FIA-MS/MS and UHPLC-MS/MS acquisition approaches used in this kit. The BAL sample data were corrected for the dilution factor since 25 µL was used versus 10 µL of the standards that were used to calculate the quantitative calibration curve. Principal component analysis of log normalized counts or concentrations were performed in R (version 4.0.2) (<xref ref-type="bibr" rid="bib48">R Development Core Team, 2021</xref>) using the prcomp() function and visualized with ggplot2 (<xref ref-type="bibr" rid="bib69">Wickham, 2016</xref>) using ggfortify (<xref ref-type="bibr" rid="bib60">Tang et al., 2016</xref>). <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref> of sample metadata was compiled with sjPlot (<xref ref-type="bibr" rid="bib35">Lüdecke, 2021</xref>) in R.</p></sec><sec id="s4-14"><title>BIOLOG phenotyping assay</title><p>Two mL of LB overnight cultures grown at 37 °C on a roller drum were washed twice with M63 salts with no carbon source by repeated centrifugation (10 min, 13 K RPM) and resuspension into fresh medium. The washed cultures were normalized to an OD<sub>600 nm</sub> = 0.05 in 25 mL of fresh M63 salts base and 100 µL was used to resuspend dehydrated carbon sources on the bottom of PM1 and PM2 BIOLOG phenotype plates by repeated pipetting. Cells and resuspended carbon were transferred to a sterile flat bottom, black-walled 96 well plate and incubated at 37 °C, static. Every hour OD<sub>600 nm</sub> was monitored in a plate reader for 24 hr. Endpoint (24 hr) data is reported. Data visualization and statistical analysis performed in GraphPad Prism 9 (version 9.2.0).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Validation, Visualization, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Funding acquisition, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Formal analysis, Funding acquisition, Methodology, Supervision, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Formal analysis, Funding acquisition, Project administration, Supervision, Validation, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Unfixed mutations observed in Pool-Seq data from evolved populations.</title><p>Fixed mutations (i.e. those mutations present at 100% across all samples at all time points) were excluded from this list as potential background differences from reference strain. All unfixed mutations are listed with unique mutation ID that consists of gene name, mutation position on the genome and the nature of the mutation. ‡ symbol indicates multiple changes within the same codon. Gene identifiers, gene name and product name indicated in Columns 2–5 (i.e. B - E) for each unique mutation ID. Columns 6 through 14 (i.e. F - N) represent the difference in the fractions of sequenced reads for the listed variants from Day 4 to Day 6 (i.e. Day 6 fraction - Day 4 fraction) for each strain and replicate. Columns 14 - end (i.e. N - AE) represent the fraction of the sequenced reads with the listed variant. Columns are labeled by gene knockout_day_replicate_fraction or change.</p></caption><media xlink:href="elife-76555-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Evolution screen for spontaneous LasR- strains in kinase deletion mutant backgrounds.</title><p>Number of replicates (three possible) with no LasR- phenotypes observed at time of plating in LB microtiter evolution assay for each clean deletion mutant. The locus tag, gene length, start and stop genomic position, gene name indicated were used to generate Circos plot shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>. Deletion mutants that displayed no LasR- phenotypes across all three replicates were followed up in a secondary 5 mL LB evolution assay.</p></caption><media xlink:href="elife-76555-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Bronchioalveolar lavage (BAL) fluid donor characteristics from people with and without cystic fibrosis (CF) used for metabolomics analyses.</title><p>Samples are grouped according to CF status with non-CF donors denoted ‘HV’ with age group, gender, CFTR genotype, and percent forced expiratory volume in 1 s at the time of encounter listed. nd, not determined.</p></caption><media xlink:href="elife-76555-supp3-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Relative metabolite counts in bronchioalveolar lavage fluid from people with cystic fibrosis (CF) and non-CF comparators by LC/MS.</title><p>Values listed for each biochemical are normalized and imputed as described in the methods section. The percent forced expiratory volume in 1 s is noted for samples from people with CF as part of the column title. For Non-CF samples, column labels are listed numerically with ‘Non-CF’ indicator. Counts are shown per sample, as the average across CF (n = 10) and non-CF (n = 10) samples and as ratio of the averages between CF and non-CF as well. Information on (sub)pathway, biochemical identifiers, and methodology shown per biochemical.</p></caption><media xlink:href="elife-76555-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Amino acid and biogenic amine concentrations in bronchioalveolar lavage (BAL) fluid from people with cystic fibrosis (CF) and non-CF comparators.</title><p>Values listed are micromolar concentrations for specified metabolites quantified in the BAL samples from people with and without CF (non-CF) using the Biocrates AbsoluteIDQ p180 Kit (n = 10 and 2, respectively). The percent forced expiratory volume in 1 s is noted for samples from people with CF as part of the column title. In addition to the concentrations listed per sample for each amino acid, the average is shown for samples from people with and without CF as well as a ratio of the averages.</p></caption><media xlink:href="elife-76555-supp5-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Strains and plasmids used in this study.</title><p>List of strains and plasmids used in this study with internal lab strain identifier, short description of strain/use including gene name and gene number, and source listed.</p></caption><media xlink:href="elife-76555-supp6-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Supplemental methods for the choice of parameters for modeling wild type and LasR- frequencies in passaged cultures.</title><p>Description of the terms for lag, growth, and death for both wild type strain PA14 and derived <italic>lasR</italic> mutants, and estimates of the number of <italic>lasR</italic> mutants in the initial population.</p></caption><media xlink:href="elife-76555-supp7-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media xlink:href="elife-76555-transrepform1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="scode1"><label>Source code 1.</label><caption><title>Matlab script for deterministic mathematical model of LasR+ (wild type) strain PA14 and lasR mutant growth following density and percentage of each strain over the course of evolution regime as described in methods.</title><p>Model parameters include growth rate, carrying capacity/concentration of saturated culture, killing rate (lysis-growth), difference in lag time (hours), and killing time at the end (hours) for each strain. Code output used to generate Figure 1A.</p></caption><media xlink:href="elife-76555-code1-v2.zip" mimetype="application" mime-subtype="zip"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All sequencing data is available on the Sequence Read Archive with accession number PRJNA786588 upon publication. All data generated or analyzed and all code used during this study are included in the manuscript or associated files.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Mould</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Pool Seq of Experimentally Evolved <italic>P. aeruginosa</italic> PA14 populations in LB</data-title><source>NCBI Sequence Read Archive</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=PRJNA786588">PRJNA786588</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>Research reported in this publication was supported by grants from the Cystic Fibrosis Foundation HOGAN19G0 (DAH), ASHARE20P0 (AA) and STANTO19R0 (DS), and the National Institutes of Health (NIH) through T32AI007519 (DLM), R01HL122372 (AA) and P20 GM130454-02 (DS). Additional core facility support came from the NIH NIGMS P20GM113132 (BioMT) and NIDDK P30-DK117469 (Dartmouth Cystic Fibrosis Research Center) and STANTO19R0 from the Cystic Fibrosis Foundation. Plasmid sequencing was carried out at Geisel School of Medicine Genomics Shared Resource, which was established by equipment grants from the NIH and NSF and is supported in part by a Cancer Center Core Grant (P30CA023108) from the NIH National Cancer Institute. We would like to acknowledge Amy Conaway for assistance in the kinase evolution screen, Dr. Georgia Doing for LasR<sup>–</sup> colony enumeration in key experiments, and Dr. Nicholas Jacobs for constructive and thoughtful feedback on the written manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abisado</surname><given-names>RG</given-names></name><name><surname>Kimbrough</surname><given-names>JH</given-names></name><name><surname>McKee</surname><given-names>BM</given-names></name><name><surname>Craddock</surname><given-names>VD</given-names></name><name><surname>Smalley</surname><given-names>NE</given-names></name><name><surname>Dandekar</surname><given-names>AA</given-names></name><name><surname>Chandler</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tobramycin Adaptation Enhances Policing of Social Cheaters in <italic>Pseudomonas aeruginosa</italic></article-title><source>Applied and Environmental Microbiology</source><volume>87</volume><elocation-id>e0002921</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.00029-21</pub-id><pub-id pub-id-type="pmid">33837019</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basan</surname><given-names>M</given-names></name><name><surname>Honda</surname><given-names>T</given-names></name><name><surname>Christodoulou</surname><given-names>D</given-names></name><name><surname>Hörl</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>Y-F</given-names></name><name><surname>Leoncini</surname><given-names>E</given-names></name><name><surname>Mukherjee</surname><given-names>A</given-names></name><name><surname>Okano</surname><given-names>H</given-names></name><name><surname>Taylor</surname><given-names>BR</given-names></name><name><surname>Silverman</surname><given-names>JM</given-names></name><name><surname>Sanchez</surname><given-names>C</given-names></name><name><surname>Williamson</surname><given-names>JR</given-names></name><name><surname>Paulsson</surname><given-names>J</given-names></name><name><surname>Hwa</surname><given-names>T</given-names></name><name><surname>Sauer</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A universal trade-off between growth and lag in fluctuating environments</article-title><source>Nature</source><volume>584</volume><fpage>470</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2505-4</pub-id><pub-id pub-id-type="pmid">32669712</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bensel</surname><given-names>T</given-names></name><name><surname>Stotz</surname><given-names>M</given-names></name><name><surname>Borneff-Lipp</surname><given-names>M</given-names></name><name><surname>Wollschläger</surname><given-names>B</given-names></name><name><surname>Wienke</surname><given-names>A</given-names></name><name><surname>Taccetti</surname><given-names>G</given-names></name><name><surname>Campana</surname><given-names>S</given-names></name><name><surname>Meyer</surname><given-names>KC</given-names></name><name><surname>Jensen</surname><given-names>PØ</given-names></name><name><surname>Lechner</surname><given-names>U</given-names></name><name><surname>Ulrich</surname><given-names>M</given-names></name><name><surname>Döring</surname><given-names>G</given-names></name><name><surname>Worlitzsch</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Lactate in cystic fibrosis sputum</article-title><source>Journal of Cystic Fibrosis</source><volume>10</volume><fpage>37</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.jcf.2010.09.004</pub-id><pub-id pub-id-type="pmid">20947455</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertrand</surname><given-names>RL</given-names></name><name><surname>Margolin</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Lag Phase Is a Dynamic, Organized, Adaptive, and Evolvable Period That Prepares Bacteria for Cell Division</article-title><source>Journal of Bacteriology</source><volume>201</volume><fpage>e00618</fpage><lpage>e00697</lpage><pub-id pub-id-type="doi">10.1128/JB.00697-18</pub-id><pub-id pub-id-type="pmid">30642990</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyle</surname><given-names>KE</given-names></name><name><surname>Monaco</surname><given-names>HT</given-names></name><name><surname>Deforet</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Rhee</surname><given-names>K</given-names></name><name><surname>Xavier</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Metabolism and the Evolution of Social Behavior</article-title><source>Molecular Biology and Evolution</source><volume>34</volume><fpage>2367</fpage><lpage>2379</lpage><pub-id pub-id-type="doi">10.1093/molbev/msx174</pub-id><pub-id pub-id-type="pmid">28595344</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castañeda-Tamez</surname><given-names>P</given-names></name><name><surname>Ramírez-Peris</surname><given-names>J</given-names></name><name><surname>Pérez-Velázquez</surname><given-names>J</given-names></name><name><surname>Kuttler</surname><given-names>C</given-names></name><name><surname>Jalalimanesh</surname><given-names>A</given-names></name><name><surname>Saucedo-Mora</surname><given-names>MÁ</given-names></name><name><surname>Jiménez-Cortés</surname><given-names>JG</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>González</surname><given-names>Y</given-names></name><name><surname>Tomás</surname><given-names>M</given-names></name><name><surname>Wood</surname><given-names>TK</given-names></name><name><surname>García-Contreras</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pyocyanin Restricts Social Cheating in <italic>Pseudomonas aeruginosa</italic></article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>1348</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.01348</pub-id><pub-id pub-id-type="pmid">29997585</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Déziel</surname><given-names>E</given-names></name><name><surname>Groleau</surname><given-names>MC</given-names></name><name><surname>Schaefer</surname><given-names>AL</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Social cheating in a <italic>Pseudomonas aeruginosa</italic> quorum-sensing variant</article-title><source>PNAS</source><volume>116</volume><fpage>7021</fpage><lpage>7026</lpage><pub-id pub-id-type="doi">10.1073/pnas.1819801116</pub-id><pub-id pub-id-type="pmid">30846553</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clay</surname><given-names>ME</given-names></name><name><surname>Hammond</surname><given-names>JH</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Kowalski</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>AJ</given-names></name><name><surname>Porter</surname><given-names>MS</given-names></name><name><surname>Hampton</surname><given-names>TH</given-names></name><name><surname>Greene</surname><given-names>CS</given-names></name><name><surname>Pletneva</surname><given-names>EV</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>Pseudomonas aeruginosa</italic> lasR mutant fitness in microoxia is supported by an Anr-regulated oxygen-binding hemerythrin</article-title><source>PNAS</source><volume>117</volume><fpage>3167</fpage><lpage>3173</lpage><pub-id pub-id-type="doi">10.1073/pnas.1917576117</pub-id><pub-id pub-id-type="pmid">31980538</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>DN</given-names></name><name><surname>Spence</surname><given-names>C</given-names></name><name><surname>Cox</surname><given-names>MJ</given-names></name><name><surname>Phibbs</surname><given-names>PV</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Isolation and phenotypic characterization of <italic>Pseudomonas aeruginosa</italic> pseudorevertants containing suppressors of the catabolite repression control-defective crc-10 allele</article-title><source>FEMS Microbiology Letters</source><volume>196</volume><fpage>87</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2001.tb10546.x</pub-id><pub-id pub-id-type="pmid">11267761</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crocker</surname><given-names>AW</given-names></name><name><surname>Harty</surname><given-names>CE</given-names></name><name><surname>Hammond</surname><given-names>JH</given-names></name><name><surname>Willger</surname><given-names>SD</given-names></name><name><surname>Salazar</surname><given-names>P</given-names></name><name><surname>Botelho</surname><given-names>NJ</given-names></name><name><surname>Jacobs</surname><given-names>NJ</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Pseudomonas aeruginosa</italic> Ethanol Oxidation by AdhA in Low-Oxygen Environments</article-title><source>Journal of Bacteriology</source><volume>201</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00393-19</pub-id><pub-id pub-id-type="pmid">31527114</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>BioCircos.js: an interactive Circos JavaScript library for biological data visualization on web applications</article-title><source>Bioinformatics (Oxford, England)</source><volume>32</volume><fpage>1740</fpage><lpage>1742</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw041</pub-id><pub-id pub-id-type="pmid">26819473</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deatherage</surname><given-names>DE</given-names></name><name><surname>Barrick</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq</article-title><source>Methods in Molecular Biology (Clifton, N.J.)</source><volume>1151</volume><fpage>165</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0554-6_12</pub-id><pub-id pub-id-type="pmid">24838886</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dettman</surname><given-names>JR</given-names></name><name><surname>Sztepanacz</surname><given-names>JL</given-names></name><name><surname>Kassen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The properties of spontaneous mutations in the opportunistic pathogen <italic>Pseudomonas aeruginosa</italic></article-title><source>BMC Genomics</source><volume>17</volume><elocation-id>27</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-2244-3</pub-id><pub-id pub-id-type="pmid">26732503</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diggle</surname><given-names>SP</given-names></name><name><surname>Griffin</surname><given-names>AS</given-names></name><name><surname>Campbell</surname><given-names>GS</given-names></name><name><surname>West</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Cooperation and conflict in quorum-sensing bacterial populations</article-title><source>Nature</source><volume>450</volume><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1038/nature06279</pub-id><pub-id pub-id-type="pmid">18004383</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Argenio</surname><given-names>DA</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>Kulasekara</surname><given-names>HD</given-names></name><name><surname>Déziel</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Ernst</surname><given-names>RK</given-names></name><name><surname>Larson Freeman</surname><given-names>TJ</given-names></name><name><surname>Spencer</surname><given-names>DH</given-names></name><name><surname>Brittnacher</surname><given-names>M</given-names></name><name><surname>Hayden</surname><given-names>HS</given-names></name><name><surname>Selgrade</surname><given-names>S</given-names></name><name><surname>Klausen</surname><given-names>M</given-names></name><name><surname>Goodlett</surname><given-names>DR</given-names></name><name><surname>Burns</surname><given-names>JL</given-names></name><name><surname>Ramsey</surname><given-names>BW</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Growth phenotypes of <italic>Pseudomonas aeruginosa</italic> lasR mutants adapted to the airways of cystic fibrosis patients</article-title><source>Molecular Microbiology</source><volume>64</volume><fpage>512</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2958.2007.05678.x</pub-id><pub-id pub-id-type="pmid">17493132</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esther</surname><given-names>CR</given-names></name><name><surname>Alexis</surname><given-names>NE</given-names></name><name><surname>Clas</surname><given-names>ML</given-names></name><name><surname>Lazarowski</surname><given-names>ER</given-names></name><name><surname>Donaldson</surname><given-names>SH</given-names></name><name><surname>Ribeiro</surname><given-names>CMP</given-names></name><name><surname>Moore</surname><given-names>CG</given-names></name><name><surname>Davis</surname><given-names>SD</given-names></name><name><surname>Boucher</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Extracellular purines are biomarkers of neutrophilic airway inflammation</article-title><source>The European Respiratory Journal</source><volume>31</volume><fpage>949</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1183/09031936.00089807</pub-id><pub-id pub-id-type="pmid">18256064</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esther</surname><given-names>CR</given-names></name><name><surname>Turkovic</surname><given-names>L</given-names></name><name><surname>Rosenow</surname><given-names>T</given-names></name><name><surname>Muhlebach</surname><given-names>MS</given-names></name><name><surname>Boucher</surname><given-names>RC</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name><name><surname>Stick</surname><given-names>SM</given-names></name><collab>AREST CF</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis</article-title><source>The European Respiratory Journal</source><volume>48</volume><fpage>1612</fpage><lpage>1621</lpage><pub-id pub-id-type="doi">10.1183/13993003.00524-2016</pub-id><pub-id pub-id-type="pmid">27836957</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>MJ</given-names></name><name><surname>Finkel</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The growth advantage in stationary-phase phenotype conferred by rpoS mutations is dependent on the pH and nutrient environment</article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>7044</fpage><lpage>7052</lpage><pub-id pub-id-type="doi">10.1128/JB.185.24.7044-7052.2003</pub-id><pub-id pub-id-type="pmid">14645263</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feltner</surname><given-names>JB</given-names></name><name><surname>Wolter</surname><given-names>DJ</given-names></name><name><surname>Pope</surname><given-names>CE</given-names></name><name><surname>Groleau</surname><given-names>MC</given-names></name><name><surname>Smalley</surname><given-names>NE</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name><name><surname>Mayer-Hamblett</surname><given-names>N</given-names></name><name><surname>Burns</surname><given-names>J</given-names></name><name><surname>Déziel</surname><given-names>E</given-names></name><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>Dandekar</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in <italic>Pseudomonas aeruginosa</italic></article-title><source>MBio</source><volume>7</volume><elocation-id>e01516</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01513-16</pub-id><pub-id pub-id-type="pmid">27703072</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finkel</surname><given-names>SE</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Evolution of microbial diversity during prolonged starvation</article-title><source>PNAS</source><volume>96</volume><fpage>4023</fpage><lpage>4027</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.7.4023</pub-id><pub-id pub-id-type="pmid">10097156</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitzpatrick</surname><given-names>AM</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Brown</surname><given-names>LAS</given-names></name><name><surname>Jones</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Children with severe asthma have unique oxidative stress-associated metabolomic profiles</article-title><source>The Journal of Allergy and Clinical Immunology</source><volume>133</volume><fpage>258</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2013.10.012</pub-id><pub-id pub-id-type="pmid">24369802</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Contreras</surname><given-names>R</given-names></name><name><surname>Loarca</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The bright side of social cheaters: potential beneficial roles of “social cheaters” in microbial communities</article-title><source>FEMS Microbiology Ecology</source><volume>97</volume><elocation-id>fiaa239</elocation-id><pub-id pub-id-type="doi">10.1093/femsec/fiaa239</pub-id><pub-id pub-id-type="pmid">33238304</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>García-Contreras</surname><given-names>R</given-names></name><name><surname>Loarca</surname><given-names>D</given-names></name><name><surname>Pérez-González</surname><given-names>C</given-names></name><name><surname>Jiménez-Cortés</surname><given-names>JG</given-names></name><name><surname>Gonzalez-Valdez</surname><given-names>A</given-names></name><name><surname>Soberón-Chávez</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Rhamnolipids stabilize quorum sensing mediated cooperation in <italic>Pseudomonas aeruginosa</italic></article-title><source>FEMS Microbiology Letters</source><volume>367</volume><elocation-id>fnaa080</elocation-id><pub-id pub-id-type="doi">10.1093/femsle/fnaa080</pub-id><pub-id pub-id-type="pmid">32407463</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groleau</surname><given-names>MC</given-names></name><name><surname>Taillefer</surname><given-names>H</given-names></name><name><surname>Vincent</surname><given-names>AT</given-names></name><name><surname>Constant</surname><given-names>P</given-names></name><name><surname>Déziel</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title><italic>Pseudomonas aeruginosa</italic> isolates defective in function of the LasR quorum sensing regulator are frequent in diverse environmental niches</article-title><source>Environmental Microbiology</source><volume>24</volume><fpage>1062</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.15745</pub-id><pub-id pub-id-type="pmid">34488244</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>JH</given-names></name><name><surname>Hebert</surname><given-names>WP</given-names></name><name><surname>Naimie</surname><given-names>A</given-names></name><name><surname>Ray</surname><given-names>K</given-names></name><name><surname>Van Gelder</surname><given-names>RD</given-names></name><name><surname>DiGiandomenico</surname><given-names>A</given-names></name><name><surname>Lalitha</surname><given-names>P</given-names></name><name><surname>Srinivasan</surname><given-names>M</given-names></name><name><surname>Acharya</surname><given-names>NR</given-names></name><name><surname>Lietman</surname><given-names>T</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name><name><surname>Zegans</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Environmentally Endemic <italic>Pseudomonas aeruginosa</italic> Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers</article-title><source>MSphere</source><volume>1</volume><fpage>e00140</fpage><lpage>e00116</lpage><pub-id pub-id-type="doi">10.1128/mSphere.00140-16</pub-id><pub-id pub-id-type="pmid">27631025</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harty</surname><given-names>CE</given-names></name><name><surname>Martins</surname><given-names>D</given-names></name><name><surname>Doing</surname><given-names>G</given-names></name><name><surname>Mould</surname><given-names>DL</given-names></name><name><surname>Clay</surname><given-names>ME</given-names></name><name><surname>Occhipinti</surname><given-names>P</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ethanol Stimulates Trehalose Production through a SpoT-DksA-AlgU-Dependent Pathway in <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>201</volume><fpage>e00794</fpage><lpage>e00718</lpage><pub-id pub-id-type="doi">10.1128/JB.00794-18</pub-id><pub-id pub-id-type="pmid">30936375</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassett</surname><given-names>DJ</given-names></name><name><surname>Ma</surname><given-names>JF</given-names></name><name><surname>Elkins</surname><given-names>JG</given-names></name><name><surname>McDermott</surname><given-names>TR</given-names></name><name><surname>Ochsner</surname><given-names>UA</given-names></name><name><surname>West</surname><given-names>SE</given-names></name><name><surname>Huang</surname><given-names>CT</given-names></name><name><surname>Fredericks</surname><given-names>J</given-names></name><name><surname>Burnett</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>PS</given-names></name><name><surname>McFeters</surname><given-names>G</given-names></name><name><surname>Passador</surname><given-names>L</given-names></name><name><surname>Iglewski</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Quorum sensing in <italic>Pseudomonas aeruginosa</italic> controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide</article-title><source>Molecular Microbiology</source><volume>34</volume><fpage>1082</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2958.1999.01672.x</pub-id><pub-id pub-id-type="pmid">10594832</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heurlier</surname><given-names>K</given-names></name><name><surname>Dénervaud</surname><given-names>V</given-names></name><name><surname>Haenni</surname><given-names>M</given-names></name><name><surname>Guy</surname><given-names>L</given-names></name><name><surname>Krishnapillai</surname><given-names>V</given-names></name><name><surname>Haas</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Quorum-sensing-negative (lasR) mutants of <italic>Pseudomonas aeruginosa</italic> avoid cell lysis and death</article-title><source>Journal of Bacteriology</source><volume>187</volume><fpage>4875</fpage><lpage>4883</lpage><pub-id pub-id-type="doi">10.1128/JB.187.14.4875-4883.2005</pub-id><pub-id pub-id-type="pmid">15995202</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>Kulasekara</surname><given-names>HD</given-names></name><name><surname>Emerson</surname><given-names>J</given-names></name><name><surname>Houston</surname><given-names>LS</given-names></name><name><surname>Burns</surname><given-names>JL</given-names></name><name><surname>Ramsey</surname><given-names>BW</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title><italic>Pseudomonas aeruginosa</italic> lasR mutants are associated with cystic fibrosis lung disease progression</article-title><source>Journal of Cystic Fibrosis</source><volume>8</volume><fpage>66</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.jcf.2008.09.006</pub-id><pub-id pub-id-type="pmid">18974024</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jørgensen</surname><given-names>KM</given-names></name><name><surname>Wassermann</surname><given-names>T</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Christiansen</surname><given-names>LE</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name><name><surname>Høiby</surname><given-names>N</given-names></name><name><surname>Ciofu</surname><given-names>Oana</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Diversity of metabolic profiles of cystic fibrosis <italic>Pseudomonas aeruginosa</italic> during the early stages of lung infection</article-title><source>Microbiology (Reading, England)</source><volume>161</volume><fpage>1447</fpage><lpage>1462</lpage><pub-id pub-id-type="doi">10.1099/mic.0.000093</pub-id><pub-id pub-id-type="pmid">25873584</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Rosa</surname><given-names>R</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Convergent Metabolic Specialization through Distinct Evolutionary Paths in <italic>Pseudomonas aeruginosa</italic></article-title><source>MBio</source><volume>9</volume><elocation-id>e00269</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00269-18</pub-id><pub-id pub-id-type="pmid">29636437</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Rosa</surname><given-names>R</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Adapting to the Airways: Metabolic Requirements of <italic>Pseudomonas aeruginosa</italic> during the Infection of Cystic Fibrosis Patients</article-title><source>Metabolites</source><volume>9</volume><elocation-id>E234</elocation-id><pub-id pub-id-type="doi">10.3390/metabo9100234</pub-id><pub-id pub-id-type="pmid">31623245</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LaFayette</surname><given-names>SL</given-names></name><name><surname>Houle</surname><given-names>D</given-names></name><name><surname>Beaudoin</surname><given-names>T</given-names></name><name><surname>Wojewodka</surname><given-names>G</given-names></name><name><surname>Radzioch</surname><given-names>D</given-names></name><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>Burns</surname><given-names>JL</given-names></name><name><surname>Dandekar</surname><given-names>AA</given-names></name><name><surname>Smalley</surname><given-names>NE</given-names></name><name><surname>Chandler</surname><given-names>JR</given-names></name><name><surname>Zlosnik</surname><given-names>JE</given-names></name><name><surname>Speert</surname><given-names>DP</given-names></name><name><surname>Bernier</surname><given-names>J</given-names></name><name><surname>Matouk</surname><given-names>E</given-names></name><name><surname>Brochiero</surname><given-names>E</given-names></name><name><surname>Rousseau</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cystic fibrosis-adapted <italic>Pseudomonas aeruginosa</italic> quorum sensing <italic>lasR</italic> mutants cause hyperinflammatory responses</article-title><source>Science Advances</source><volume>1</volume><elocation-id>e1500199</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1500199</pub-id><pub-id pub-id-type="pmid">26457326</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>A</given-names></name><name><surname>Preuße</surname><given-names>M</given-names></name><name><surname>Bruchmann</surname><given-names>S</given-names></name><name><surname>Pawar</surname><given-names>V</given-names></name><name><surname>Grahl</surname><given-names>N</given-names></name><name><surname>Pils</surname><given-names>MC</given-names></name><name><surname>Nolan</surname><given-names>LM</given-names></name><name><surname>Filloux</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Häussler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Importance of flagella in acute and chronic <italic>Pseudomonas aeruginosa</italic> infections</article-title><source>Environmental Microbiology</source><volume>21</volume><fpage>883</fpage><lpage>897</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.14468</pub-id><pub-id pub-id-type="pmid">30411474</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Lüdecke</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>sjPlot: Data Visualization for Statistics in Social Science (Version R package version 2.8.10)</article-title><source>SjPlot</source><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=sjPlot">https://CRAN.R-project.org/package=sjPlot</ext-link><date-in-citation iso-8601-date="2021-11-26">November 26, 2021</date-in-citation></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luján</surname><given-names>AM</given-names></name><name><surname>Moyano</surname><given-names>AJ</given-names></name><name><surname>Segura</surname><given-names>I</given-names></name><name><surname>Argaraña</surname><given-names>CE</given-names></name><name><surname>Smania</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Quorum-sensing-deficient (lasR) mutants emerge at high frequency from a <italic>Pseudomonas aeruginosa</italic> mutS strain</article-title><source>Microbiology (Reading, England)</source><volume>153</volume><fpage>225</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1099/mic.0.29021-0</pub-id><pub-id pub-id-type="pmid">17185551</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCready</surname><given-names>AR</given-names></name><name><surname>Paczkowski</surname><given-names>JE</given-names></name><name><surname>Henke</surname><given-names>BR</given-names></name><name><surname>Bassler</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural determinants driving homoserine lactone ligand selection in the <italic>Pseudomonas aeruginosa</italic> LasR quorum-sensing receptor</article-title><source>PNAS</source><volume>116</volume><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1073/pnas.1817239116</pub-id><pub-id pub-id-type="pmid">30559209</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monod</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1949">1949</year><article-title>THE GROWTH OF BACTERIAL CULTURES</article-title><source>Annual Review of Microbiology</source><volume>3</volume><fpage>371</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1146/annurev.mi.03.100149.002103</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mould</surname><given-names>DL</given-names></name><name><surname>Botelho</surname><given-names>NJ</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Intraspecies Signaling between Common Variants of <italic>Pseudomonas aeruginosa</italic> Increases Production of Quorum-Sensing-Controlled Virulence Factors</article-title><source>MBio</source><volume>11</volume><elocation-id>e01865-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01865-20</pub-id><pub-id pub-id-type="pmid">32843558</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mould</surname><given-names>DL</given-names></name><name><surname>Hogan</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Intraspecies heterogeneity in microbial interactions</article-title><source>Current Opinion in Microbiology</source><volume>62</volume><fpage>14</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2021.04.003</pub-id><pub-id pub-id-type="pmid">34034081</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neidhardt</surname><given-names>FC</given-names></name><name><surname>Bloch</surname><given-names>PL</given-names></name><name><surname>Smith</surname><given-names>DF</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>Culture medium for enterobacteria</article-title><source>Journal of Bacteriology</source><volume>119</volume><fpage>736</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1128/jb.119.3.736-747.1974</pub-id><pub-id pub-id-type="pmid">4604283</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O Brien</surname><given-names>S</given-names></name><name><surname>Lujan</surname><given-names>AM</given-names></name><name><surname>Paterson</surname><given-names>S</given-names></name><name><surname>Cant</surname><given-names>MA</given-names></name><name><surname>Buckling</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adaptation to public goods cheats in <italic>Pseudomonas aeruginosa</italic></article-title><source>Proceedings. Biological Sciences</source><volume>284</volume><elocation-id>20171089</elocation-id><pub-id pub-id-type="doi">10.1098/rspb.2017.1089</pub-id><pub-id pub-id-type="pmid">28747481</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozkaya</surname><given-names>O</given-names></name><name><surname>Balbontín</surname><given-names>R</given-names></name><name><surname>Gordo</surname><given-names>I</given-names></name><name><surname>Xavier</surname><given-names>KB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cheating on Cheaters Stabilizes Cooperation in <italic>Pseudomonas aeruginosa</italic></article-title><source>Current Biology</source><volume>28</volume><fpage>2070</fpage><lpage>2080</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.04.093</pub-id><pub-id pub-id-type="pmid">30008329</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Connor</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>CY</given-names></name><name><surname>Diggle</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Frequency of Quorum Sensing Mutations in <italic>Pseudomonas aeruginosa</italic> Strains Isolated from Different Environments</article-title><source>Microbiology</source><volume>1</volume><elocation-id>365</elocation-id><pub-id pub-id-type="doi">10.1101/2021.02.22.432365</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Toole</surname><given-names>GA</given-names></name><name><surname>Gibbs</surname><given-names>KA</given-names></name><name><surname>Hager</surname><given-names>PW</given-names></name><name><surname>Phibbs</surname><given-names>PV</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>182</volume><fpage>425</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1128/JB.182.2.425-431.2000</pub-id><pub-id pub-id-type="pmid">10629189</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>KL</given-names></name><name><surname>Mashburn</surname><given-names>LM</given-names></name><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Whiteley</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Cystic fibrosis sputum supports growth and cues key aspects of <italic>Pseudomonas aeruginosa</italic> physiology</article-title><source>Journal of Bacteriology</source><volume>187</volume><fpage>5267</fpage><lpage>5277</lpage><pub-id pub-id-type="doi">10.1128/JB.187.15.5267-5277.2005</pub-id><pub-id pub-id-type="pmid">16030221</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Toll-Riera</surname><given-names>M</given-names></name><name><surname>Heilbron</surname><given-names>K</given-names></name><name><surname>Preston</surname><given-names>GM</given-names></name><name><surname>MacLean</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The genomic basis of adaptation to the fitness cost of rifampicin resistance in <italic>Pseudomonas aeruginosa</italic></article-title><source>Proceedings. Biological Sciences</source><volume>283</volume><elocation-id>1822</elocation-id><pub-id pub-id-type="doi">10.1098/rspb.2015.2452</pub-id><pub-id pub-id-type="pmid">26763710</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2021">2021</year><data-title>R: A language and environment for statistical computing</data-title><version designator="2.6.2">2.6.2</version><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robitaille</surname><given-names>S</given-names></name><name><surname>Groleau</surname><given-names>MC</given-names></name><name><surname>Déziel</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Swarming motility growth favours the emergence of a subpopulation of <italic>Pseudomonas aeruginosa</italic> quorum-sensing mutants</article-title><source>Environmental Microbiology</source><volume>22</volume><fpage>2892</fpage><lpage>2906</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.15042</pub-id><pub-id pub-id-type="pmid">32337826</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigue</surname><given-names>A</given-names></name><name><surname>Quentin</surname><given-names>Y</given-names></name><name><surname>Lazdunski</surname><given-names>A</given-names></name><name><surname>Méjean</surname><given-names>V</given-names></name><name><surname>Foglino</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Two-component systems in <italic>Pseudomonas aeruginosa</italic>: why so many?</article-title><source>Trends in Microbiology</source><volume>8</volume><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/s0966-842x(00)01833-3</pub-id><pub-id pub-id-type="pmid">11121759</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rumbaugh</surname><given-names>KP</given-names></name><name><surname>Diggle</surname><given-names>SP</given-names></name><name><surname>Watters</surname><given-names>CM</given-names></name><name><surname>Ross-Gillespie</surname><given-names>A</given-names></name><name><surname>Griffin</surname><given-names>AS</given-names></name><name><surname>West</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Quorum sensing and the social evolution of bacterial virulence</article-title><source>Current Biology</source><volume>19</volume><fpage>341</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2009.01.050</pub-id><pub-id pub-id-type="pmid">19230668</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoz</surname><given-names>KM</given-names></name><name><surname>Mitzimberg</surname><given-names>SM</given-names></name><name><surname>Schuster</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Social cheating in <italic>Pseudomonas aeruginosa</italic> quorum sensing</article-title><source>PNAS</source><volume>104</volume><fpage>15876</fpage><lpage>15881</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705653104</pub-id><pub-id pub-id-type="pmid">17898171</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuster</surname><given-names>M</given-names></name><name><surname>Lostroh</surname><given-names>CP</given-names></name><name><surname>Ogi</surname><given-names>T</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Identification, timing, and signal specificity of <italic>Pseudomonas aeruginosa</italic> quorum-controlled genes: a transcriptome analysis</article-title><source>Journal of Bacteriology</source><volume>185</volume><fpage>2066</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1128/JB.185.7.2066-2079.2003</pub-id><pub-id pub-id-type="pmid">12644476</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schuster</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Early activation of quorum sensing in <italic>Pseudomonas aeruginosa</italic> reveals the architecture of a complex regulon</article-title><source>BMC Genomics</source><volume>8</volume><elocation-id>287</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-8-287</pub-id><pub-id pub-id-type="pmid">17714587</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scribner</surname><given-names>MR</given-names></name><name><surname>Stephens</surname><given-names>AC</given-names></name><name><surname>Huong</surname><given-names>JL</given-names></name><name><surname>Richardson</surname><given-names>AR</given-names></name><name><surname>Cooper</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The Nutritional Environment Is Sufficient To Select Coexisting Biofilm and Quorum Sensing Mutants of <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>204</volume><elocation-id>e0044421</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00444-21</pub-id><pub-id pub-id-type="pmid">34978461</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shanks</surname><given-names>RMQ</given-names></name><name><surname>Caiazza</surname><given-names>NC</given-names></name><name><surname>Hinsa</surname><given-names>SM</given-names></name><name><surname>Toutain</surname><given-names>CM</given-names></name><name><surname>O’Toole</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title><italic>Saccharomyces cerevisiae</italic>        -Based Molecular Tool Kit for Manipulation of Genes from Gram-Negative Bacteria</article-title><source>Applied and Environmental Microbiology</source><volume>72</volume><fpage>5027</fpage><lpage>5036</lpage><pub-id pub-id-type="doi">10.1128/AEM.00682-06</pub-id><pub-id pub-id-type="pmid">16820502</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>EE</given-names></name><name><surname>Buckley</surname><given-names>DG</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Saenphimmachak</surname><given-names>C</given-names></name><name><surname>Hoffman</surname><given-names>LR</given-names></name><name><surname>D’Argenio</surname><given-names>DA</given-names></name><name><surname>Miller</surname><given-names>SI</given-names></name><name><surname>Ramsey</surname><given-names>BW</given-names></name><name><surname>Speert</surname><given-names>DP</given-names></name><name><surname>Moskowitz</surname><given-names>SM</given-names></name><name><surname>Burns</surname><given-names>JL</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Olson</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic adaptation by <italic>Pseudomonas aeruginosa</italic> to the airways of cystic fibrosis patients</article-title><source>PNAS</source><volume>103</volume><fpage>8487</fpage><lpage>8492</lpage><pub-id pub-id-type="doi">10.1073/pnas.0602138103</pub-id><pub-id pub-id-type="pmid">16687478</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnleitner</surname><given-names>E</given-names></name><name><surname>Abdou</surname><given-names>L</given-names></name><name><surname>Haas</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Small RNA as global regulator of carbon catabolite repression in <italic>Pseudomonas aeruginosa</italic></article-title><source>PNAS</source><volume>106</volume><fpage>21866</fpage><lpage>21871</lpage><pub-id pub-id-type="doi">10.1073/pnas.pnas.0910308106</pub-id><pub-id pub-id-type="pmid">20080802</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnleitner</surname><given-names>E</given-names></name><name><surname>Prindl</surname><given-names>K</given-names></name><name><surname>Bläsi</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The <italic>Pseudomonas aeruginosa</italic> CrcZ RNA interferes with Hfq-mediated riboregulation</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0180887</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0180887</pub-id><pub-id pub-id-type="pmid">28686727</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Horikoshi</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ggfortify: Unified Interface to Visualize Statistical Results of Popular R Packages</article-title><source>The R Journal</source><volume>8</volume><elocation-id>474</elocation-id><pub-id pub-id-type="doi">10.32614/RJ-2016-060</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twomey</surname><given-names>KB</given-names></name><name><surname>Alston</surname><given-names>M</given-names></name><name><surname>An</surname><given-names>S-Q</given-names></name><name><surname>O’Connell</surname><given-names>OJ</given-names></name><name><surname>McCarthy</surname><given-names>Y</given-names></name><name><surname>Swarbreck</surname><given-names>D</given-names></name><name><surname>Febrer</surname><given-names>M</given-names></name><name><surname>Dow</surname><given-names>JM</given-names></name><name><surname>Plant</surname><given-names>BJ</given-names></name><name><surname>Ryan</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e82432</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0082432</pub-id><pub-id pub-id-type="pmid">24358183</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Delden</surname><given-names>C</given-names></name><name><surname>Pesci</surname><given-names>EC</given-names></name><name><surname>Pearson</surname><given-names>JP</given-names></name><name><surname>Iglewski</surname><given-names>BH</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Starvation selection restores elastase and rhamnolipid production in a <italic>Pseudomonas aeruginosa</italic> quorum-sensing mutant</article-title><source>Infection and Immunity</source><volume>66</volume><fpage>4499</fpage><lpage>4502</lpage><pub-id pub-id-type="doi">10.1128/IAI.66.9.4499-4502.1998</pub-id><pub-id pub-id-type="pmid">9712807</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Delden</surname><given-names>C</given-names></name><name><surname>Comte</surname><given-names>R</given-names></name><name><surname>Bally</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Stringent response activates quorum sensing and modulates cell density-dependent gene expression in <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>5376</fpage><lpage>5384</lpage><pub-id pub-id-type="doi">10.1128/JB.183.18.5376-5384.2001</pub-id><pub-id pub-id-type="pmid">11514523</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Schaefer</surname><given-names>AL</given-names></name><name><surname>Dandekar</surname><given-names>AA</given-names></name><name><surname>Greenberg</surname><given-names>Ep</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Quorum sensing and policing of <italic>Pseudomonas aeruginosa</italic> social cheaters</article-title><source>PNAS</source><volume>112</volume><fpage>2187</fpage><lpage>2191</lpage><pub-id pub-id-type="doi">10.1073/pnas.1500704112</pub-id><pub-id pub-id-type="pmid">25646454</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>BX</given-names></name><name><surname>Cady</surname><given-names>KC</given-names></name><name><surname>Oyarce</surname><given-names>GC</given-names></name><name><surname>Ribbeck</surname><given-names>K</given-names></name><name><surname>Laub</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Two-Component Signaling Systems Regulate Diverse Virulence-Associated Traits in <italic>Pseudomonas aeruginosa</italic></article-title><source>Applied and Environmental Microbiology</source><volume>87</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.1128/AEM.03089-20</pub-id><pub-id pub-id-type="pmid">33771779</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>SA</given-names></name><name><surname>Griffin</surname><given-names>AS</given-names></name><name><surname>Gardner</surname><given-names>A</given-names></name><name><surname>Diggle</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Social evolution theory for microorganisms</article-title><source>Nature Reviews. Microbiology</source><volume>4</volume><fpage>597</fpage><lpage>607</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1461</pub-id><pub-id pub-id-type="pmid">16845430</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteley</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>KM</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Identification of genes controlled by quorum sensing in <italic>Pseudomonas aeruginosa</italic></article-title><source>PNAS</source><volume>96</volume><fpage>13904</fpage><lpage>13909</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.24.13904</pub-id><pub-id pub-id-type="pmid">10570171</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whiteley</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Promoter specificity elements in <italic>Pseudomonas aeruginosa</italic> quorum-sensing-controlled genes</article-title><source>Journal of Bacteriology</source><volume>183</volume><fpage>5529</fpage><lpage>5534</lpage><pub-id pub-id-type="doi">10.1128/JB.183.19.5529-5534.2001</pub-id><pub-id pub-id-type="pmid">11544214</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2: Elegent Graphics for Data Analysis</source><publisher-loc>Cham</publisher-loc><publisher-name>Springer-Verlag</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstanley</surname><given-names>C</given-names></name><name><surname>O’Brien</surname><given-names>S</given-names></name><name><surname>Brockhurst</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Pseudomonas aeruginosa</italic> Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections</article-title><source>Trends in Microbiology</source><volume>24</volume><fpage>327</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2016.01.008</pub-id><pub-id pub-id-type="pmid">26946977</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>A</given-names></name><name><surname>Rodrigue</surname><given-names>N</given-names></name><name><surname>Kassen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genomics of adaptation during experimental evolution of the opportunistic pathogen <italic>Pseudomonas aeruginosa</italic></article-title><source>PLOS Genetics</source><volume>8</volume><elocation-id>e1002928</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002928</pub-id><pub-id pub-id-type="pmid">23028345</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>X</given-names></name><name><surname>Xia</surname><given-names>B</given-names></name><name><surname>Weng</surname><given-names>Y</given-names></name><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Ren</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in <italic>Pseudomonas aeruginosa</italic></article-title><source>MBio</source><volume>11</volume><elocation-id>e02079</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02079-19</pub-id><pub-id pub-id-type="pmid">31911486</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>F</given-names></name><name><surname>Dandekar</surname><given-names>AA</given-names></name><name><surname>Shen</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>Na</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A Metabolic Trade-Off Modulates Policing of Social Cheaters in Populations of <italic>Pseudomonas aeruginosa</italic></article-title><source>Frontiers in Microbiology</source><volume>9</volume><elocation-id>337</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2018.00337</pub-id><pub-id pub-id-type="pmid">29535700</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Haagensen</surname><given-names>JAJ</given-names></name><name><surname>Jelsbak</surname><given-names>L</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name><name><surname>Sternberg</surname><given-names>C</given-names></name><name><surname>Høiby</surname><given-names>N</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>In situ growth rates and biofilm development of <italic>Pseudomonas aeruginosa</italic> populations in chronic lung infections</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>2767</fpage><lpage>2776</lpage><pub-id pub-id-type="doi">10.1128/JB.01581-07</pub-id><pub-id pub-id-type="pmid">18156255</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>ATY</given-names></name><name><surname>Bains</surname><given-names>M</given-names></name><name><surname>Hancock</surname><given-names>REW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The sensor kinase CbrA is a global regulator that modulates metabolism, virulence, and antibiotic resistance in <italic>Pseudomonas aeruginosa</italic></article-title><source>Journal of Bacteriology</source><volume>193</volume><fpage>918</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1128/JB.00911-10</pub-id><pub-id pub-id-type="pmid">21169488</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zambrano</surname><given-names>MM</given-names></name><name><surname>Siegele</surname><given-names>DA</given-names></name><name><surname>Almirón</surname><given-names>M</given-names></name><name><surname>Tormo</surname><given-names>A</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Microbial competition: <italic>Escherichia coli</italic> mutants that take over stationary phase cultures</article-title><source>Science (New York, N.Y.)</source><volume>259</volume><fpage>1757</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1126/science.7681219</pub-id><pub-id pub-id-type="pmid">7681219</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinser</surname><given-names>ER</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase</article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>5800</fpage><lpage>5807</lpage><pub-id pub-id-type="doi">10.1128/JB.181.18.5800-5807.1999</pub-id><pub-id pub-id-type="pmid">10482523</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinser</surname><given-names>ER</given-names></name><name><surname>Kolter</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Prolonged stationary-phase incubation selects for lrp mutations in <italic>Escherichia coli</italic> K-12</article-title><source>Journal of Bacteriology</source><volume>182</volume><fpage>4361</fpage><lpage>4365</lpage><pub-id pub-id-type="doi">10.1128/JB.182.15.4361-4365.2000</pub-id><pub-id pub-id-type="pmid">10894750</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Reagent type (species) or resource</th><th align="left" valign="top">Designation</th><th align="left" valign="top">Source or reference</th><th align="left" valign="top">Identifiers</th><th align="left" valign="top">Additional information</th></tr></thead><tbody><tr><td align="left" valign="top">Gene (<italic>Pseudomonas aeruginosa</italic>)</td><td align="left" valign="top">PA14</td><td align="left" valign="top">NCBI</td><td align="left" valign="top">Accession: GCF_000014625.1</td><td align="left" valign="top">Reference file</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Saccharomyces cerevisiae</italic>)</td><td align="left" valign="top"><italic>Saccharomyces cerevisiae</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16820502/">16820502</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Cloning yeast</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="top">DH5a</td><td align="left" valign="top">Invitrogen</td><td align="left" valign="top"/><td align="left" valign="top">Electrocompetent cells</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>Escherichia coli</italic>)</td><td align="left" valign="top">S17 λpir</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8226632/">8226632</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Electrocompetent cells made in lab</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 WT</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7604262/">7604262</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Hogan Laboratory reference strain</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">DH2417; NC-AMT0101-1-2</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16687478/">16687478</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Chronic CF lung infection isolate with functional LasR allele</td></tr><tr><td align="left" valign="top">Strain, strain background (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 WT</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Laub Lab; strain background of kinase clean deletion mutants</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa)</italic></td><td align="left" valign="top">PA14 <italic>∆lasR</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15554963/">15554963</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PAO-MW1qsc102</td><td align="left" valign="top">PMID:10570171; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11544214/">11544214</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">AHL-sensing bioreporter; PAO1 <italic>lasIrhlI</italic> mutant with Tn5-B22, which contains promoterless <italic>lacZ</italic> located within PA1896 (hypothetical protein) at chromosomal location of 2,067,716. Responsive to 3OC<sub>12</sub>-HSL but not C<sub>4</sub>-HSL.</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PAO-MW1qsc131</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10570171/">10570171</ext-link>; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11544214/">11544214</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">AHL-sensing bioreporter; PAO1 <italic>lasIrhlI</italic> mutant with Tn5-B22, which contains promoterless <italic>lacZ,</italic> under <italic>phzC</italic> promoter control. Responsive to either 3OC<sub>12</sub>-HSL or C<sub>4</sub>-HSL but requires both for full activation.</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 WT <italic>att::lacZ</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31980538/">31980538</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT with constitutive expression of <italic>lacZ</italic> for competition assays</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>cheA</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>chpA</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>creC</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>uhpB</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>bfiS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>bphP</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_10770</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_11630</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>rocS1</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>narX</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>wspE</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_19340</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>mxtR</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>cpxS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>gtrS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_24340</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>rocS2</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_26810</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>sagS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>copS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pfeS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>bqsS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_30700</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_30840</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>czcS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_32570</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_36420</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>ercS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆e<italic>xaD</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>ercS’</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>parS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>kdpD</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_43670</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_45590</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_45870</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_46370</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_46980</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_48160</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>phoQ</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_49420</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>fleS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pirS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>gacS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>tctE</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pprA</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>colS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_57170</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>roxS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>rcsC</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pvrS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pilS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>cbrA</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>pmrB</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>retS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_64580</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>aruS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>ntrB</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_68230</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>amgS</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>algZ</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>phoR</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>kinB</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆PA14_72740</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33771779/">33771779</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>rhlR</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30936375/">30936375</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆anr</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31527114/">31527114</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT with in-frame deletion of <italic>cbrB</italic> (PA14_62540)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>cbrB</italic>::Tn<italic>M</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22911607/">22911607</ext-link>; PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16477005/">16477005</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"><italic>cbrB MAR2xT7</italic> transposon insertion mutant</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">DH2417∆<italic>cbrB</italic>; NC-AMT0101-1-2∆<italic>cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">CF clinical isolate NC-AMT0101-1-2 (DH2417) with in-frame deletion of <italic>cbrB</italic> (PA14_62540)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>crc</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT with in-frame deletion of <italic>crc</italic> (PA14_70390)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>crc</italic> + <italic>crc</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>crc</italic> with complementation of <italic>crc</italic> (PA14_70390) at the native locus</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR + lasR</italic></td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31980538/">31980538</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 ∆<italic>cbrB</italic> + pMQ70 <italic>cbrB</italic> (plasmid)</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>cbrB</italic> expressing arabinose inducible pMQ70 <italic>cbrB</italic> expression vector</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR</italic>∆<italic>cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>lasR</italic> with in-frame deletion of <italic>cbrB</italic> (PA14_62540)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR</italic>∆<italic>cbrB</italic> + <italic>cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>lasR</italic>∆<italic>cbrB</italic> with complementation of <italic>cbrB</italic> (PA14_62540) at the native locus</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR</italic>∆<italic>cbrB∆crc</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>lasR</italic>∆<italic>cbrB</italic> with in-frame deletion of <italic>crc</italic> (PA14_70390)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR∆crc</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>lasR</italic> with in-frame deletion of <italic>crc</italic> (PA14_70390)</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 <italic>∆lasR∆crc</italic> + <italic>crc</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 ∆<italic>lasR</italic>∆<italic>crc</italic> with complementation of <italic>crc</italic> (PA14_70390) at the native locus</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 + pMQ72 EV</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT expressing pMQ72 empty vector</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 + pMQ70 <italic>cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT expressing arabinose inducible pMQ70 <italic>cbrB</italic> expression vector</td></tr><tr><td align="left" valign="top">Genetic reagent (<italic>P. aeruginosa</italic>)</td><td align="left" valign="top">PA14 + pMQ72 <italic>crcZ</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">PA14 WT expressing arabinose inducible pMQ72 <italic>crcZ</italic> expression vector</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ30 EV</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16820502/">16820502</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ72 EV</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16820502/">16820502</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ70 EV</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16820502/">16820502</ext-link></td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ30<italic>_cbrB_</italic>KO</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ30 plasmid for knocking out <italic>cbrb</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ30<italic>_crc_</italic>KO</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ30 plasmid for knocking out <italic>crc</italic></td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ30<italic>_cbrB_</italic>KON</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ30 plasmid for complementing <italic>cbrb</italic> at the native locus</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ30<italic>_crc_</italic>KON</td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ30 plasmid for complementing <italic>cbrb</italic> at the native locus</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ72<italic>_crcZ</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ72 plasmid backbone with arabinose inducible <italic>crcZ</italic> expression</td></tr><tr><td align="left" valign="top">Recombinant DNA reagent</td><td align="left" valign="top">pMQ70<italic>_cbrB</italic></td><td align="left" valign="top">This paper</td><td align="left" valign="top"/><td align="left" valign="top">pMQ70 plasmid backbone with arabinose inducible <italic>cbrB</italic> expression</td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ72 crcZ OE 1 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">gtttctccatacccgtttttttgggctagcGCACAACAACAATA</named-content><named-content content-type="sequence">ACAAGCAACGACGAAG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ72 crcZ OE 2 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">ctagaggatccccgggtaccgagctcgaattcgaaatggtgtaaggcgaaggaaaaacgg</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ70 <italic>cbrB</italic> OE 1 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">ctctctactgtttctccatacccgtttttttgggctagcgAGACGAGCgaattcACGTCGAGAGAGCtgaatacatggcac</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ70 <italic>cbrB</italic> OE 2 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">ttgcatgcctgcaggtcgactctagaggatccccgggtacGTAACAGGTTGCAGGGTaccGTtacgagtcggccgaggcccc</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>cbrB</italic> KO 1 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">taacaatttcacacaggaaacagctatgaccatgattacgaattcAGGAAGTGCTGATGTGGAACC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>cbrB</italic> KO 2 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">GTAACAGGTTGCAGGGTGTTTATTCAGCTCTCTCGACGTGCT</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>cbrB</italic> KO 3 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">CACGTCGAGAGAGCTGAATAAACACCCTGCAACCTGTTACC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>cbrB</italic> KO 4 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">aggtcgactctagaggatccccgggtaccgagctcgaattcCAGGGAGTGCTGGTTGTTACCGATGACTtc</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>crc</italic> KO 1 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">taacaatttcacacaggaaacagctatgaccatgattacgaattcTGGAATACAGGCGCAGCAac</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>crc</italic> KO 2 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">TAGAAAAGCCGGCGCATGCGCTGGCTTTTTCGTGTCTGACGGGGCAAATGGCCCCCAAAATCACGTGCG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>crc</italic> KO 4 R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">ctgcaggtcgactctagaggatccccgggtaccgagctcgaattcttggctgaccgccgagtacggcatgc</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">pMQ30 <italic>crc</italic> KO 3 F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR Primers; construct design</td><td align="left" valign="top"><named-content content-type="sequence">TTTGAGCTCGGGTATCATACACGCACGTGATTTTGGGGGCCATTTGCCCCGTCAGACACGAAAAAGCCAG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>cbrB</italic> check F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR primer, KO check</td><td align="left" valign="top"><named-content content-type="sequence">GCGTCTGCTCCCTGGCCAAG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>cbrB</italic> check R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR primer, KO check</td><td align="left" valign="top"><named-content content-type="sequence">GTGGCGCTGGTGGCGACATC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>crc</italic> check F</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR primer, KO check</td><td align="left" valign="top"><named-content content-type="sequence">GCTCGATGGCGAAACGAATG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top"><italic>crc</italic> check R</td><td align="left" valign="top">This paper</td><td align="left" valign="top">PCR primer, KO check</td><td align="left" valign="top"><named-content content-type="sequence">GCGCTGGTGTTGACCATCATC</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">crcZ RT 1 F</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31911486/">31911486</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">GCACAACAACAATAACAAGCAACG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">crcZ RT 2 R</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31911486/">31911486</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">AGTTTTATTCTTCTTCCGACTGGCT</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">rpsL RT1F</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31911486/">31911486</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">GTAAGGTATGCCGTGTACG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">rpsL RT 2 R</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31911486/">31911486</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">CACTACGCTGTGCTCTTG</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">rpoD RT 1 F</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30936375/">30936375</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">CGCCGAGATCAAGGAAATCA</named-content></td></tr><tr><td align="left" valign="top">Sequence-based reagent</td><td align="left" valign="top">rpoD RT 2 R</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30936375/">30936375</ext-link></td><td align="left" valign="top">PCR Primers</td><td align="left" valign="top"><named-content content-type="sequence">TACTTCTTGGCGATGGAAATCA</named-content></td></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">NEBuilder HiFi DNA Assembly</td><td align="left" valign="top">Biolabs</td><td align="left" valign="top">Cat. #: E2621L</td><td align="left" valign="top">Gibson cloning</td></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Master Pure Yeast DNA purification kit</td><td align="left" valign="top">Lucigen</td><td align="left" valign="top">Cat. No.: MPY80200</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">RNAeasy Mini kit</td><td align="left" valign="top">QIAGEN</td><td align="left" valign="top">Cat. No.: 74,104</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Turbo DNA-free kit</td><td align="left" valign="top">Thermo Fisher Scientific</td><td align="left" valign="top">AM1907</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">RevertAid H Minus First Strand cDNA synthesis</td><td align="left" valign="top">Thermo Scientific</td><td align="left" valign="top">Cat. No.: EP0451</td><td align="left" valign="top">cDNA synthesis with IDT random hexamer</td></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">SsoFast EvaGreen Supermix</td><td align="left" valign="top">BIO-RAD</td><td align="left" valign="top">Cat.#: 1725201</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Zymoprep Yeast Plasmid Miniprep II</td><td align="left" valign="top">Zymo Research</td><td align="left" valign="top">Cat. No.: D2004</td><td align="left" valign="top">Yeast cloning</td></tr><tr><td align="left" valign="top">Commercial assay, kit</td><td align="left" valign="top">Biocrates AbsoluteIDQ p180 kit</td><td align="left" valign="top">biocrates</td><td align="left" valign="top"/><td align="left" valign="top">Amino acid. quantification</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Brain Heart Infusion</td><td align="left" valign="top">BD</td><td align="left" valign="top">SKU:211,059</td><td align="left" valign="top">BBL Brain Heart Infusion</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Agar</td><td align="left" valign="top">BD</td><td align="left" valign="top">SKU:214,510</td><td align="left" valign="top">Difco Agar, granulated (2 Kg pail)</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">XGAL; 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside</td><td align="left" valign="top">Research Products International</td><td align="left" valign="top">B71800-5.0</td><td align="left" valign="top">Stock dissolved in DMSO</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Fluoroacetamide</td><td align="left" valign="top">Aldrich</td><td align="left" valign="top">128341–5 G</td><td align="left" valign="top">dissolved in water, filter sterilized</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Lactamide</td><td align="left" valign="top">Tokyo Chemical Industry</td><td align="left" valign="top">Product Number: L0001</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Mannitol</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">M8429-500G</td><td align="left" valign="top">D-Mannitol</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Succinate</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">S9512-500G</td><td align="left" valign="top">Succinic acid, to pH7 with NaOH</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Phenylalanine</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">P2126-100G</td><td align="left" valign="top">L-Phenylalanine</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Arginine</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">A5131-100G</td><td align="left" valign="top">L-arginine monohydrochloride</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Lactate</td><td align="left" valign="top">Fisher Scientific</td><td align="left" valign="top">S326-500</td><td align="left" valign="top">Sodium lactate syrup, 60% w/w</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Glucose</td><td align="left" valign="top">VWR Chemicals</td><td align="left" valign="top">BDH9230-2.5KG</td><td align="left" valign="top">Dextrose, anhydrous</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Citrate</td><td align="left" valign="top">FisherScientific</td><td align="left" valign="top">A104-500</td><td align="left" valign="top">Citric acid, monohydrate</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Gentamicin</td><td align="left" valign="top">Research Products International</td><td align="left" valign="top">G38000-10.0</td><td align="left" valign="top">Gentamicin Sulfate</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Nalidixic acid</td><td align="left" valign="top">Research Products International</td><td align="left" valign="top">N42000-25.0</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Carbinicillin</td><td align="left" valign="top">Goldbio</td><td align="left" valign="top">C-103–25</td><td align="left" valign="top">Carbenicillin (Disodium)</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sucrose</td><td align="left" valign="top">Fisher BioReagents</td><td align="left" valign="top">BP220-212; 2.5 kg</td><td align="left" valign="top">D-Sucrose</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">HEPES</td><td align="left" valign="top">SIGMA</td><td align="left" valign="top">H3375-100G</td><td align="left" valign="top">buffer</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Tryptone</td><td align="left" valign="top">Fisher Bioreagents</td><td align="left" valign="top">BP1421-500</td><td align="left" valign="top">LB</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">NaCl; sodium chloride</td><td align="left" valign="top">Fisher Chemical</td><td align="left" valign="top">S271-3</td><td align="left" valign="top">LB</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Yeast extract</td><td align="left" valign="top">Fisher Bioreagents</td><td align="left" valign="top">BP1422-500</td><td align="left" valign="top">LB</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Ammonium sulfate</td><td align="left" valign="top">Fisher Chemical</td><td align="left" valign="top">A702-500</td><td align="left" valign="top">M63</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium phosphate monobasic</td><td align="left" valign="top">Fisher Chemical</td><td align="left" valign="top">P382-500</td><td align="left" valign="top">M63</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium phosphate dibasic, anhydrous</td><td align="left" valign="top">Fisher Chemical</td><td align="left" valign="top">P288-500</td><td align="left" valign="top">M63</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Magnesium Sulfate</td><td align="left" valign="top">Fisher Scientific</td><td align="left" valign="top">M63-500</td><td align="left" valign="top">M63</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Milk</td><td align="left" valign="top">BD</td><td align="left" valign="top">232,100</td><td align="left" valign="top">Difco Skim Milk</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Yeast Nitrogen Base without amino acids</td><td align="left" valign="top">Research Products International</td><td align="left" valign="top">Y20040-500.0</td><td align="left" valign="top">Yeast cloning</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Yeast Synthetic Drop-out Medium Supplements without uracil</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">Y1501-20G</td><td align="left" valign="top">Yeast cloning</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Peptone</td><td align="left" valign="top">Fisher bioreagents</td><td align="left" valign="top">BP1420-500</td><td align="left" valign="top">YPD</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sodium phosphate dibasic anhydrous</td><td align="left" valign="top">Fisher Chemicals</td><td align="left" valign="top">S374-500</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Sodium phosphate monobasic</td><td align="left" valign="top">Fisher Chemicals</td><td align="left" valign="top">S369-500</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium Nitrate</td><td align="left" valign="top">Fisher Chemicals</td><td align="left" valign="top">M-12636</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Potassium Sulfate</td><td align="left" valign="top">Fisher Chemicals</td><td align="left" valign="top">P304-500</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">L-(+)-Lactic acid</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">L1750-10G</td><td align="left" valign="top">ASM; 1 M stock; pH to 7 with NaOH</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Calcium chloride dihydrate</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">C7902-500G</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Magnesium Chloride Hexahydrate</td><td align="left" valign="top">Fisher chemical</td><td align="left" valign="top">M33-500</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">FeSO<sub>4</sub>*7H<sub>2</sub>O</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">F-8048</td><td align="left" valign="top">ASM; Ferrous sulfate heptahydrate; Filter sterilized</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">N-acetylglucosamine</td><td align="left" valign="top">Fisher Scientific</td><td align="left" valign="top">AAA1304718</td><td align="left" valign="top">ASM</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">DPPC</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">P0763-250MG</td><td align="left" valign="top">ASM; 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; dissolved in chloroform</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Tryptophan</td><td align="left" valign="top">Sigma-Aldrich</td><td align="left" valign="top">T0254-25G</td><td align="left" valign="top">ASM, L-Tryptophan</td></tr><tr><td align="left" valign="top">Chemical compound, drug</td><td align="left" valign="top">Mucin</td><td align="left" valign="top">Sigma</td><td align="left" valign="top">M2378-100G</td><td align="left" valign="top">ASM; Mucin from porcine stomach, Type II</td></tr><tr><td align="left" valign="top">Peptide, recombinant protein</td><td align="left" valign="top">Phusion</td><td align="left" valign="top">New England BioLabs</td><td align="left" valign="top">M0530L</td><td align="left" valign="top">High-Fidelity DNA polymerase</td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">MATLAB</td><td align="left" valign="top">MathWorks</td><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">breseq</td><td align="left" valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24838886/">24838886</ext-link></td><td align="left" valign="top"/><td align="left" valign="top">Version 0.35.4</td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">bcl2fastq</td><td align="left" valign="top">Illumina</td><td align="left" valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_015058">SCR_015058</ext-link></td><td align="left" valign="top">v2.20.0422</td></tr><tr><td align="left" valign="top">Software, algorithm</td><td align="left" valign="top">GraphPad Prism 9</td><td align="left" valign="top">GraphPad</td><td align="left" valign="top"/><td align="left" valign="top">Version 9.2.0</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76555.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cooper</surname><given-names>Vaughn S</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.01.14.476307" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.14.476307"/></front-stub><body><p>This study aimed to identify the genetic foundation favoring selection of lasR mutants in laboratory and clinical isolates from persons with CF. They selected these mutants using a predictable and quantitative framework of evolution experiments and then identified their genetic underpinnings by a suppressor screen. The role of cbrAB as a key intermediate is important and ties together several reports of nutrient-dependent advantages of lasR, including those that may explain their adaptation to conditions found in the CF airway.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76555.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Cooper</surname><given-names>Vaughn S</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Kram</surname><given-names>Karin</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04pyvbw03</institution-id><institution>CSU Dominguez Hills</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.14.476307">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.01.14.476307v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Metabolic basis for the evolution of a common pathogenic <italic>Pseudomonas aeruginosa</italic> variant&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Gisela Storz as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Karin Kram (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) Please clarify the open questions of the complexity of the CF nutritional environment selecting for lasR mutants, which are also selected in multiple, simpler environments.</p><p>2) It's unclear whether the QS (dys-)function of lasR- is necessary to explain these results; mutants appear to be selected independent of a social interaction with producers. Please address.</p><p>3) Figure 1E: The authors state that the model predicted the extent to which LasR- outcompeted the WT, but the model appears to have predicted slightly higher percentages for the LasR- strain than observed in the experiment. Is this difference significant? Should this finding be interpreted as evidence that other phenotypes of LasR- mutants beyond metabolic adaptations contribute to some extent to their fitness?</p><p>4) Line 213/Figure 2A: Although the selection of LasR- mutants was delayed in the CF mutant (DH2417), LasR- phenotypes still consistently occurred and rose to high frequencies. This is a major point that suggests that CbrB may play a role but is not required for LasR- mutant fitness in certain genetic backgrounds. The wording in line 213 and conclusions throughout ought to carefully reflect this point.</p><p>5) Line 404: It is curious that crc mutations occur in a ∆cbrB background but are not frequently observed in vivo or in a WT background. While it is true that the effect of a ∆crc mutant is not identical the effect of a lasR mutation, the ∆crc mutant still appears to produce many similar phenotypes but to a different magnitude. While this pathway is required for LasR- mutant fitness, is it possible that phenotypes unrelated to this pathway also contribute to LasR- mutant fitness, enabling their selection?</p><p>6) It is not clear whether or why ∆anr or ∆rhlR strains are used to compare rates of LasR- mutations.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>This is an exceptionally thorough and well-written manuscript. Comments for the authors are indicated below.</p><p>Figure 1E: The authors state that the model predicted the extent to which LasR- outcompeted the WT, but the model appears to have predicted slightly higher percentages for the LasR- strain than observed in the experiment. Is this difference significant? Should this finding be interpreted as evidence that other phenotypes of LasR- mutants beyond metabolic adaptations contribute to some extent to their fitness?</p><p>Line 213/Figure 2A: Although the selection of LasR- mutants was delayed in the CF mutant (DH2417), LasR- phenotypes still consistently occurred and rose to high frequencies. This is a major point that suggests that CbrB may play a role but is not required for LasR- mutant fitness in certain genetic backgrounds. The wording in line 213 and conclusions throughout ought to carefully reflect this point.</p><p>Figure 4: Do the authors have experimental data to model growth parameters of lasR mutants in their ASM medium? This would be interesting to compare with the LB data in Figure 1.</p><p>Line 404: It is curious that crc mutations occur in a ∆cbrB background but are not frequently observed in vivo or in a WT background. While it is true that the effect of a ∆crc mutant is not identical the effect of a lasR mutation, the ∆crc mutant still appears to produce many similar phenotypes but to a different magnitude. While this pathway is required for LasR- mutant fitness, is it possible that phenotypes unrelated to this pathway also contribute to LasR- mutant fitness, enabling their selection?</p><p>Line 548: Does read trimming refer to trimming of Illumina adapters, to other quality-control related trimming procedures, or both? Please briefly indicate the software and parameters used for this step.</p><p>Line 552: Was variant calling analysis performed using the -p option to call polymorphisms? If so, please add this detail to the example command.</p><p>Supplemental Figure 6B: Lines should not connect the data points in this figure as the x-axis is categorical.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>I might mention quorum sensing/the function of LasR somewhere in the abstract, especially since that is the opening paragraph in the introduction.</p><p>Figure 1A: For the model, why OD600 instead of CFU/ml or cells?</p><p>Figure 1B: y-axis should just be % LasR phenotype (since it shows both + and -).</p><p>Figure 1E is not particularly clear nor do I think this experiment adds much, since you already show that LasR- mutants can outcompete even when starting as a very low percentage of the population.</p><p>Line 244: citation twice.</p><p>Line 289: maybe you could add something to the end of this sentence like, &quot;retains the control of Crc-Hfq mediated regulation, allowing for Crc expression, even when crcZ is repressed.&quot; The way this sentence is written currently is a bit hard to decipher.</p><p>Line 294: Do you know nothing else increases crcZ expression?</p><p>Figure 4C: It is really difficult to determine which metabolites are important or significant (the way it is right now it looks like all are labeled as significant, but that can't be true). Maybe just show the ones that are significantly different here (or a subset), and the rest in a supplemental figure? You don't explain the pvalue in the legend, or the colors.</p><p>I am not sure the experiment in 4D is particularly additive, since the LasR- phenotype does not evolve faster or more dramatically in LB. It indicates that these can still evolve in ASM, but there is nothing specific about ASM. Also, it should be clear in the text that this is the same passaging scheme as was used previously.</p><p>Why do you think no gain of function mutations, or those that lead to increased expression, are found for cbrA/cbrB? Why there may be no loss-of-function crc mutations is briefly addressed.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76555.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Please clarify the open questions of the complexity of the CF nutritional environment selecting for lasR mutants, which are also selected in multiple, simpler environments.</p></disp-quote><p>We agree that this would be a useful addition to the text. We have added the following sentence to the Introduction.</p><p>“While it is clear that there are many ways in which LasR loss-of-function mutants differ from their LasR+ progenitors, a common trait that promotes the rise of LasR– strains in diverse environments, even in rich and minimal laboratory media (Heurlier et al., 2005; Scribner, Stephens, Huong, Richardson, and Cooper, 2022) (O'Brien, Luján, Paterson, Cant, and Buckling, 2017) (Lujan, Moyano, Segura, Argarana, and Smania, 2007; Qi, Toll-Riera, Heilbron, Preston, and MacLean, 2016; Robitaille, Groleau, and Déziel, 2020; Sandoz et al., 2007; Wong, Rodrigue, and Kassen, 2012; Yan et al., 2018), has not been established.”</p><p>We also added text to the Discussion that highlights how the complex CF lung environment may provide multiple positive and negative selective pressures.</p><p>“Unlike <italic>lasR</italic> mutations, <italic>crc</italic> mutations are not commonly observed in clinical isolates (Winstanley, O'Brien, and Brockhurst, 2016) and <italic>crc</italic> mutants have been shown to be under negative selection in Tn-Seq experiments (Lorenz et al., 2019).”</p><disp-quote content-type="editor-comment"><p>2) It's unclear whether the QS (dys-)function of lasR- is necessary to explain these results; mutants appear to be selected independent of a social interaction with producers. Please address.</p></disp-quote><p>Overall, our data suggest that LasR- selection is independent of social interaction and driven by growth differences under the conditions assessed in this paper. The concordance between the modeling described in Figure 1A, which does not include any terms for positive or negative interactions, and the actual data shown in Figure 1B is one of the major pieces of data in support of this conclusion. We have revised our description of the motivation for the model in the revised manuscript.</p><p>“We built a mathematical model of strain competition based exclusively on experimentally-determined mono-culture growth parameters to predict the relative changes in wild type and LasR– cell numbers when grown on a common pool of growth substrates to determine how differences in growth kinetics alone would impact the rise of LasR– lineages (Figure 1A).”</p><p>We have also revised the description of Figure 1E to indicate that it does not show density dependent fitness for LasR strains under our conditions, which suggests that “cheating” does not play a driving role for the improved growth of LasR- <italic>P. aeruginosa</italic> in co-culture.</p><p>“When the ∆<italic>lasR</italic> competitor was cultured with the tagged wild type for 6 h, the percentage of ∆<italic>lasR</italic> mutant cells in the total population increased regardless of the initial percentage of ∆<italic>lasR</italic> (1% to 85%) at the time of inoculation (Figure 1E). The model successfully predicted that ∆<italic>lasR</italic> would outcompete the wild type over this range which is consistent with differential growth kinetics playing a major role (Figure 1E-dotted line). No ∆<italic>lasR</italic> advantage would be observed when it is at high initial percentages if its advantage was solely due to exploitation of common goods, as is observed when WT and ∆<italic>lasR</italic> are co-cultured on a substrate that requires WT protease production (Sandoz et al., 2007). There were differences between the best fit lines for the actual and predicted data that could be due to a variety of factors including measurement error or biological interactions between WT and ∆<italic>lasR</italic> strains (e.g. policing Castañeda-Tamez et al., 2018; M. Wang et al., 2015).”</p><p>We have also added the following text to the manuscript discussion:</p><p>“The overlap between the model-predicted and observed percentages of LasR<sup>–</sup> strains over the course of the evolution regime suggests that the described social advantage resulting from QS dysfunction for LasR<sup>–</sup> strains (i.e. social cheating) is not necessary to explain the timing and kinetics of the initial rise of LasR<sup>–</sup> strains under our conditions. However, social interactions that benefit LasR- strains may be evident where the model estimates percentages that fall below or on the lower range of that experimentally observed, such as Day 4 or 6. A more detailed discussion of when social interactions are required is found below.”</p><disp-quote content-type="editor-comment"><p>3) Figure 1E: The authors state that the model predicted the extent to which LasR- outcompeted the WT, but the model appears to have predicted slightly higher percentages for the LasR- strain than observed in the experiment. Is this difference significant? Should this finding be interpreted as evidence that other phenotypes of LasR- mutants beyond metabolic adaptations contribute to some extent to their fitness?</p></disp-quote><p>In the revised the description of Figure 1E, we discuss the fact that the model predicts higher percentages of LasR- strains than observed. We speculate that this could be due to decreased fitness of LasR- strains in the presence of LasR+ strains. This may relate to “policing” mechanisms by which wild type strains kill LasR- strains through a variety of secreted goods as a way of controlling the levels which LasR- strains reach. We have added text to this effect to the discussion.</p><disp-quote content-type="editor-comment"><p>4) Line 213/Figure 2A: Although the selection of LasR- mutants was delayed in the CF mutant (DH2417), LasR- phenotypes still consistently occurred and rose to high frequencies. This is a major point that suggests that CbrB may play a role but is not required for LasR- mutant fitness in certain genetic backgrounds. The wording in line 213 and conclusions throughout ought to carefully reflect this point.</p></disp-quote><p>We agree that in LB the loss of <italic>cbrB</italic> delayed and reduced the percentage of LasR- strains in the CF isolate, but that LasR- colonies still arose (Figure 2B), and that we did not accurately note this in the referenced sentence. We have corrected this.</p><p>In addition, we added the following text to the discussion:</p><p>“It is interesting to note that there were differences in the relative dependence on CbrB for the selection for LasR<sup>–</sup> between strains PA14 and DH2417, and in ASM the dependence on <italic>cbrB</italic> for the selection of LasR<sup>–</sup> strains increased in both strains (Figure 4D) suggesting that different environments may alter the importance of different LasR and CbrB controlled targets important for fitness that have yet to be elucidated.</p><disp-quote content-type="editor-comment"><p>5) Line 404: It is curious that crc mutations occur in a ∆cbrB background but are not frequently observed in vivo or in a WT background. While it is true that the effect of a ∆crc mutant is not identical the effect of a lasR mutation, the ∆crc mutant still appears to produce many similar phenotypes but to a different magnitude. While this pathway is required for LasR- mutant fitness, is it possible that phenotypes unrelated to this pathway also contribute to LasR- mutant fitness, enabling their selection?</p></disp-quote><p>We have modified text to address this interesting point as follows:</p><p>“Because CbrAB activity can still be suppressed by succinate in LasR<sup>–</sup> cells (Figure 2E), LasR<sup>–</sup> variants were not strictly “de-repressed”, and this is consistent with the fact that ∆<italic>lasR</italic> and ∆<italic>crc</italic> growth patterns were not identical. Unlike <italic>lasR</italic> mutations, <italic>crc</italic> mutations are not commonly observed in clinical isolates (Winstanley, O'Brien, and Brockhurst, 2016) and <italic>crc</italic> mutants have been shown to be under negative selection in Tn-Seq experiments (Lorenz et al., 2019).”</p><disp-quote content-type="editor-comment"><p>6) It is not clear whether or why ∆anr or ∆rhlR strains are used to compare rates of LasR- mutations.</p></disp-quote><p>We revised the text to clarify the motivation for these experiments as follows:</p><p>“LasR<sup>–</sup> strains rose with a similar frequency as in the wild type progenitor when evolution experiments were initiated with strains lacking the regulator Anr, important for LasR<sup>–</sup> microoxic fitness, or the regulator RhlR, important for <italic>lasR</italic> mutant policing (Chen, Déziel, Groleau, Schaefer, and Greenberg, 2019; Clay et al., 2020) suggesting that these regulators were not major contributors to fitness under these conditions (Figure 2 —figure supplement 2B).”</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>This is an exceptionally thorough and well-written manuscript. Comments for the authors are indicated below.</p><p>Lines 49 and 80: Inconsistencies in citation format are present in a few instances.</p></disp-quote><p>Thank you. We think that this refers to the fact that the <italic>eLife</italic> Endnote output style only lists one author when the author list is long.</p><disp-quote content-type="editor-comment"><p>Figure 1E: The authors state that the model predicted the extent to which LasR- outcompeted the WT, but the model appears to have predicted slightly higher percentages for the LasR- strain than observed in the experiment. Is this difference significant? Should this finding be interpreted as evidence that other phenotypes of LasR- mutants beyond metabolic adaptations contribute to some extent to their fitness?</p></disp-quote><p>This comment was included in essential comments and is addressed above.</p><disp-quote content-type="editor-comment"><p>Line 213/Figure 2A: Although the selection of LasR- mutants was delayed in the CF mutant (DH2417), LasR- phenotypes still consistently occurred and rose to high frequencies. This is a major point that suggests that CbrB may play a role but is not required for LasR- mutant fitness in certain genetic backgrounds. The wording in line 213 and conclusions throughout ought to carefully reflect this point.</p></disp-quote><p>This comment was included in essential comments and is addressed above.</p><disp-quote content-type="editor-comment"><p>Figure 2C: It is not clear what the arrows are pointing at.</p></disp-quote><p>To improve clarity, we have removed the arrows and added detail about the larger colony size in text and figure legend.</p><disp-quote content-type="editor-comment"><p>Figure 4: Do the authors have experimental data to model growth parameters of lasR mutants in their ASM medium? This would be interesting to compare with the LB data in Figure 1.</p></disp-quote><p>We agree that this would be interesting. Because ASM is not optically clear, we cannot measure cellular numbers using the same parameters/tools used for LB (OD600). The code included in this manuscript for the mathematical model (Source Code File 1) can be used by the community and the parameters altered for growth in other conditions.</p><disp-quote content-type="editor-comment"><p>Line 404: It is curious that crc mutations occur in a ∆cbrB background but are not frequently observed in vivo or in a WT background. While it is true that the effect of a ∆crc mutant is not identical the effect of a lasR mutation, the ∆crc mutant still appears to produce many similar phenotypes but to a different magnitude. While this pathway is required for LasR- mutant fitness, is it possible that phenotypes unrelated to this pathway also contribute to LasR- mutant fitness, enabling their selection?</p></disp-quote><p>This comment was included in essential comments and is addressed above.</p><disp-quote content-type="editor-comment"><p>Line 548: Does read trimming refer to trimming of Illumina adapters, to other quality-control related trimming procedures, or both? Please briefly indicate the software and parameters used for this step.</p></disp-quote><p>Read trimming was performed with bcl2fastq (v2.20.0422) to remove Illumina adaptor sequences during the demultiplexing process. This information has been added to the methods.</p><disp-quote content-type="editor-comment"><p>Line 552: Was variant calling analysis performed using the -p option to call polymorphisms? If so, please add this detail to the example command.</p></disp-quote><p>Variant calling analysis was performed using the -p option to call polymorphisms. We have added this detail to the example command.</p><disp-quote content-type="editor-comment"><p>Supplemental Figure 6B: Lines should not connect the data points in this figure as the x-axis is categorical.</p></disp-quote><p>Agreed. We have removed the line.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>I might mention quorum sensing/the function of LasR somewhere in the abstract, especially since that is the opening paragraph in the introduction.</p></disp-quote><p>Thank you. We have added text on the function of LasR to the abstract.</p><disp-quote content-type="editor-comment"><p>Figure 1A: For the model, why OD600 instead of CFU/ml or cells?</p></disp-quote><p>Given that the model was built on data obtained as OD600, as a proxy for cell number, we maintained this as an output for the model. We note that OD600 correlates with cell number shown in panel B.</p><disp-quote content-type="editor-comment"><p>Figure 1B: y-axis should just be % LasR phenotype (since it shows both + and -).</p></disp-quote><p>Thank you. We have corrected the y-axis in Figure 1B and Figure 2F as well.</p><disp-quote content-type="editor-comment"><p>Figure 1B legend should explain the differences in the symbols (not just the text).</p></disp-quote><p>We have added this detail to the legend.</p><disp-quote content-type="editor-comment"><p>Figure 1E is not particularly clear nor do I think this experiment adds much, since you already show that LasR- mutants can outcompete even when starting as a very low percentage of the population.</p></disp-quote><p>We revised the text describing this figure. We feel that it is useful to compare to other studies that assess social interactions, which we discuss in more detail in this manuscript (see Essential Comment 3).</p><disp-quote content-type="editor-comment"><p>Line 289: maybe you could add something to the end of this sentence like, &quot;retains the control of Crc-Hfq mediated regulation, allowing for Crc expression, even when crcZ is repressed.&quot; The way this sentence is written currently is a bit hard to decipher.</p></disp-quote><p>Thank you for this suggestion. We have altered the text and figure to highlight the point that <italic>lasR</italic> mutants respond to succinate while <italic>crc</italic> mutants do not.</p><disp-quote content-type="editor-comment"><p>Line 294: Do you know nothing else increases crcZ expression?</p></disp-quote><p>Because we can’t rule out players other than CbrAB in the control of crcZ, we have modified this sentence to say:</p><p>“CbrAB activity induces the expression of <italic>crcZ</italic>, which sequesters Crc. We found that the ∆<italic>lasR</italic> mutant had ~ two-fold higher <italic>crcZ</italic> levels compared to wild type, suggesting higher activity of the CbrAB two component system in LasR<sup>–</sup> strains (Figure 3A).”</p><disp-quote content-type="editor-comment"><p>Figure 4C: It is really difficult to determine which metabolites are important or significant (the way it is right now it looks like all are labeled as significant, but that can't be true). Maybe just show the ones that are significantly different here (or a subset), and the rest in a supplemental figure? You don't explain the pvalue in the legend, or the colors.</p></disp-quote><p>In this figure we are not comparing individual carbon sources, but rather the relative density of WT and ∆<italic>lasR</italic> across those carbon sources present on BIOLOG PM-1 and PM-2 plates that were enriched in the CF lung. We have added additional details to the text, legend and figure for clarification. Thank you.</p><disp-quote content-type="editor-comment"><p>I am not sure the experiment in 4D is particularly additive, since the LasR- phenotype does not evolve faster or more dramatically in LB. It indicates that these can still evolve in ASM, but there is nothing specific about ASM. Also, it should be clear in the text that this is the same passaging scheme as was used previously.</p></disp-quote><p>We retained this figure and now discuss that while the kinetics for the increase in LasR- are similar in LB and ASM, it is interesting that the dependence on <italic>cbrB</italic> for LasR- lineage selection (particularly for strain 2417) is greater in ASM. We have added this observation to the discussion to highlight how environment may affect fitness as discussed above (see Essential Comment 4).</p><p>We have added text to indicate that the evolution scheme is similar.</p><disp-quote content-type="editor-comment"><p>Why do you think no gain of function mutations, or those that lead to increased expression, are found for cbrA/cbrB? Why there may be no loss-of-function crc mutations is briefly addressed.</p></disp-quote><p>There is one mutation found in an upstream region of CbrB, though the impact of this mutation on expression is currently unknown. It would be interesting if it were a gain of function in terms of expression.</p><p>We have expanded our discussion of the negative fitness of <italic>crc</italic> single mutants in the revised discussion, and believe that they only frequently rise to detectable levels in <italic>cbrB</italic> mutant populations.</p></body></sub-article></article>